Triticale cultivar 343CMS and novel sequences for male sterility

ABSTRACT

A cytoplasmic male sterile triticale cultivar, designated 343CMS, is disclosed. The invention relates to the seeds of triticale cultivar 343CMS, to the plants of triticale 343CMS, and to methods for producing a triticale plant produced by crossing the cultivar 343CMS with itself or another triticale variety. The invention also relates to methods for producing a triticale plant containing in its genetic material one or more transgenes and to the transgenic triticale plants and plant parts produced by those methods. The invention also relates to triticale varieties or breeding varieties and plant parts derived from triticale cultivar 343CMS, to methods for producing other triticale varieties, lines or plant parts derived from triticale cultivar 343CMS, and to the triticale plants, varieties, and their parts derived from the use of those methods. The invention further relates to hybrid triticale seeds and plants produced by crossing the cultivar 343CMS with another triticale cultivar.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to provisional application U.S. Ser.No. 62/938,690, filed Nov. 21, 2019, which is incorporated herein byreference in its entirety.

SEQUENCE LISTING

The instant application contains a Sequence Listing which has beensubmitted in ASCII format via EFS-Web and is hereby incorporated byreference in its entirety. Said ASCII copy, created on Nov. 19, 2020, isnamed 2020-11-19_SEARS_P12671W001_SEQLISTING ST25.txt and is 204,606bytes in size.

BACKGROUND

Triticale (Triticale hexaploide L.) is a crop species resulting from across between wheat (Triticum) and rye (Secale). It is a man-made cropin that plant breeders must physically make crosses and then manipulatethe resultant offspring to obtain a self-fertile plant. Triticales areagronomically desirable due to their ideal combinations of the yield andquality advantages of common wheat, and the hardiness, pest tolerance,and adaptability of rye.

Hybrids of wheat and rye date back to the late 1800's, however earlyattempts to cross wheat and rye produced only sterile offspring, so formany years triticale was only a scientific novelty. Fertile triticalescapable of producing viable seed were virtually unknown until the late1930's when a Swedish geneticist named Arne Muntzing produced fertiletriticale by treating the hybrids with colchicines, which doubled thechromosome number allowing reproductive pairing and division to occur.With normal pairing and division, triticale could be reproduced throughsubsequent generations. Once a fertile hybrid of triticale was produced,it became possible to create new combinations between wheat and rye andto intercross triticale with various common wheat. Triticale became anew crop plant, similar to, but distinct from common wheat, rye, andother cereal grains in breeding, seed production, and use. Once createdand reproduced, a triticale does not revert or break-down to itsoriginal wheat and rye components.

Development of hybrid plant breeding has made possible considerableadvances in quality and quantity of crops produced. Increased yield andcombination of desirable characteristics, such as resistance to diseaseand insects, heat and drought tolerance, along with variations in plantcomposition are all possible because of hybridization procedures. Theseprocedures frequently rely heavily on providing for a male parentcontributing pollen to a female parent to produce the resulting hybrid.

Field crops are bred through techniques that take advantage of theplant's method of pollination. A plant is self-pollinated if pollen fromone flower is transferred to the same or another flower of the sameplant or a genetically identical plant. A plant is cross-pollinated ifthe pollen comes from a flower on a genetically different plant. Incertain species, such as Brassica campestris, the plant is normallyself-sterile and can only be cross-pollinated. In predominantlyself-pollinating species, such as soybeans, wheat, and cotton, the maleand female plants are anatomically juxtaposed such that during naturalpollination, the male reproductive organs of a given flower pollinatethe female reproductive organs of the same flower. Triticale, as withwheat, is predominantly self-pollinating, though considerableoutcrossing may occur. Male sterile triticale lines are useful in ahybrid production system.

SUMMARY

Provided here is triticale seed, a triticale plant, plant parts, atriticale cultivar and a method for producing a triticale plant. Furtherprovided are methods of producing triticale seeds and plants by crossinga plant of the instant invention with another triticale plant. Thecytoplasmic male sterile plant is useful in hybridization systems.

The compositions and methods relate to seeds of triticale line 343CMS,to the plants of triticale line 343CMS and to methods for producing atriticale plant produced by crossing the triticale 343CMS with itself oranother triticale plant. Thus, any such methods using the triticale line343CMS are part of this invention, including selfing after restorationof fertility, backcrosses, hybrid production, crosses to populations,and the like.

In another aspect, single trait converted plants of 343CMS are provided.The single transferred trait may preferably be a dominant or recessiveallele. Preferably, the single transferred trait will confer such traitsas herbicide resistance, insect resistance, resistance for bacterial,fungal, or viral disease, male fertility, male sterility, and industrialusage. The single trait may be a naturally occurring triticale gene or atransgene introduced through genetic engineering techniques.

In another aspect is provided regenerable cells for use in tissueculture of triticale plant 343CMS. The tissue culture will preferably becapable of regenerating plants having the physiological andmorphological characteristics of the foregoing triticale plant, and ofregenerating plants having substantially the same genotype as theforegoing triticale plant. Preferably, the regenerable cells in suchtissue cultures will be embryos, protoplasts, meristematic cells,callus, plant clumps, pollen, ovules, pericarp, seeds, flowers, florets,heads, spikes, leaves, roots, root tips, anthers, stems, and the like.Still further, the present invention provides triticale plantsregenerated from the tissue cultures of the invention.

Applicants have further identified novel sequence variants ofmitochondrial genes that are associated with the male sterile phenotypepresent in variety 343CMS. Disclosed herein are novel sequences ofmitochondrial Atp synthase 8-1 gene (Atp8-1), NAD9/NAD7 mitochondrialnicotinamide adenine dinucleotide dehydrogenase (NAD9), and NADHdehydrogenase subunit 4L (NAD4L) which may be used to introduce the malesterile phenotype into other wheat, triticale or cereal plants byback-crossing, transformation, gene editing and the like, or used as amarker to identify male sterile varieties for use and selection inbreeding to develop further male sterile varieties.

The sequences include SEQ ID NOs: 32, 48, 64, 66, and 68, theirconservatively modified variants, and sequences with 80, 85, 90, 95, 96,97, 98 or 99 percent homology thereto which include the novel variantnucleotides of the disclosure including an Atp8-1 nucleic acid sequenceassociated with a male sterile phenotype comprising one or more of: a Cat position 155, a C at position 176, an A at position 186 and/or a C atposition 337 as depicted in FIG. 2 ; an NAD9 nucleic acid sequenceassociated with a male sterile phenotype comprising one or more of thefollowing: a C at position 170, an A at position 187 and/or a G atposition 338 as depicted in FIG. 3 ; and an NAD4L nucleic acid sequenceassociated with a male sterile phenotype comprising one or more of thefollowing: a C at position 51, an A at position 54, a C at position 57,a G at position 61, a T at position 64, a C at position 69, a G atposition 74, a G at position 75, an A at position 89, a G at position93, an A at position 95, a G at position 97, an A at position 199, a Cat position 202, an A at position 206, a T at position 207, a T atposition 208, a G at position 210, an A at position 212, a G at position213, a C at position 214, a C at position 215, a T at position 218, a Cat position 219, a C at position 220, a T at position 221, a T atposition 222, a C at position 223, a C at position 225, a T at position226, a C at position 227, a G at position 237, and/or a C at position238 as depicted in FIG. 4 .

In some embodiments, the Atp8-1 nucleic acid sequence comprises one ormore of: a C at position 56, a C at position 77, an A at position 87and/or a C at position 238 when compared to wild type reference SEQ IDNO: 65 or as set forth in SEQ ID NO: 66. In some embodiments, the NAD9nucleic acid sequence comprises one or more of: a C at position 118, anA at position 135 and/or a G at position 286 when compared to wild typereference SEQ ID NO: 67 or as set forth in SEQ ID NO: 68.

The sequences include SEQ ID NOs: 70 and 72, their conservativelymodified variants, and sequences with 80, 85, 90, 95, 96, 97, 98 or 99percent homology thereto which include the novel variant polypeptides ofthe disclosure including an Atp8-1 polypeptide associated with a malesterile phenotype comprising one or more of: a P residue at position 19,a P residue at position 26, a K residue at position 29, and/or a Presidue at position 80 when compared to wild type reference SEQ ID NO:69 or as set forth in SEQ ID NO: 70; and an NAD9 polypeptide sequenceassociated with a male sterile phenotype comprising one or more of thefollowing: an H residue at position 40, an A residue at position 45and/or an A residue at position 96 when compared to wild type referenceSEQ ID NO: 71 or as set forth in SEQ ID NO: 72.

Compositions and methods for modulating male fertility in a plant areprovided. Compositions comprise expression cassettes comprising one ormore mitochondrial male-fertility polynucleotides, or fragments orvariants thereof, operably linked to a promoter, wherein expression ofthe polynucleotide modulates the male fertility of a plant. Variousmethods are provided wherein the level and/or activity of apolynucleotide or polypeptide that influences male fertility ismodulated in a plant or plant part. Methods for identifying and/orselecting plants plants that are homozygous or heterozygous for amutation that induces male sterility are also provided. In addition tothe exemplary aspects and embodiments described above, further aspectsand embodiments will become apparent by study of the followingdescriptions.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a graphic showing multiple sequence alignment at nucleotidelevel of the mitochondrial cytochrome coxidase III (Cox3) gene (SEQ IDNOs: 1-16). All the accessions used in the study are labelled 1 through13 and 15 through 17 with gene prefix (sequence 14 is omitted here andin FIGS. 2-4 ). Triticale line 343CMS is shown at number 12. Sequencechange of interest is highlighted with asterisk (*) and nucleotideposition. Nucleotides 371-420 of SEQ ID NO: 1, nucleotides 368-417 ofSEQ ID NO: 2, nucleotides 370-419 of SEQ ID NO: 3, nucleotides 373-422of SEQ ID NO: 4, nucleotides 370-419 of SEQ ID NO: 5, nucleotides371-417 of SEQ ID NO: 6, nucleotides 372-421 of SEQ ID NO: 7,nucleotides 372-421 of SEQ ID NO: 8, nucleotides 373-422 of SEQ ID NO:9, nucleotides 373-422 of SEQ ID NO: 10, nucleotides 365-393 of SEQ IDNO: 11, nucleotides 373-422 of SEQ ID NO: 12, nucleotides 373-422 of SEQID NO: 13, nucleotides 355-404 of SEQ ID NO: 14, nucleotides 373-422 ofSEQ ID NO: 15, and nucleotides 370-419 of SEQ ID NO: 16 are shown.

FIG. 2 is a graphic showing multiple sequence alignment at nucleotidelevel of the mitochondrial Atp synthase 8-1 gene (Atp8-1) (SEQ ID NOs:17-32). All the accessions used in the study are labelled 1-13 and 15-17with gene prefix. Triticale line 343CMS is number 12. Sequence change ofinterest is highlighted with asterisk (*) and nucleotide position.Nucleotides 144-193 and 294-343 of SEQ ID NO: 17, nucleotides 136-185and 286-335 of SEQ ID NO: 18, nucleotides 137-186 and 287-336 of SEQ IDNO: 19, nucleotides 135-184 and 285-334 of SEQ ID NO: 20, nucleotides130-179 and 280-329 of SEQ ID NO: 21, nucleotides 136-185 and 286-335 ofSEQ ID NO: 22, nucleotides 136-185 and 286-335 of SEQ ID NO: 23,nucleotides 136-185 and 286-335 of SEQ ID NO: 24, nucleotides 137-186and 287-336 of SEQ ID NO: 25, nucleotides 137-186 and 287-336 of SEQ IDNO: 26, nucleotides 139-188 and 289-338 of SEQ ID NO: 27, nucleotides143-192 and 293-342 of SEQ ID NO: 28, nucleotides 137-186 and 287-336 ofSEQ ID NO: 29, nucleotides 61-63 and 119-168 of SEQ ID NO: 30,nucleotides 136-185 and 286-335 of SEQ ID NO: 31, and nucleotides139-188 and 289-338 of SEQ ID NO: 32 are shown.

FIG. 3 is a graphic showing multiple sequence alignment at nucleotidelevel of the mitochondrial NAD9/NAD7 mitochondrial nicotinamide adeninedinucleotide dehydrogenase (NAD9) gene (SEQ ID NOs: 33-48). All theaccessions used in the study are labelled 1-13 and 15-17 with geneprefix. Triticale 343CMS is number 12. Sequence change of interest ishighlighted with asterisk (*) and nucleotide position. Nucleotides150-195 and 296-345 of SEQ ID NO: 33, nucleotides 146-191 and 292-341 ofSEQ ID NO: 34, nucleotides 147-192 and 293-342 of SEQ ID NO: 35,nucleotides 147-192 and 293-342 of SEQ ID NO: 36, nucleotides 117-132and 213-240 of SEQ ID NO: 37, nucleotides 147-192 and 293-342 of SEQ IDNO: 38, nucleotides 147-192 and 293-342 of SEQ ID NO: 39, nucleotides146-195 and 296-345 of SEQ ID NO: 40, nucleotides 151-200 and 301-350 ofSEQ ID NO: 41, nucleotides 144-193 and 294-343 of SEQ ID NO: 42,nucleotides 146-195 and 296-345 of SEQ ID NO: 43, nucleotides 146-195and 296-345 of SEQ ID NO: 44, nucleotides 147-196 and 297-346 of SEQ IDNO: 45, nucleotides 144-192 and 286-308 of SEQ ID NO: 46, nucleotides147-196 and 297-346 of SEQ ID NO: 47, and nucleotides 148-197 and298-347 of SEQ ID NO: 48 are shown.

FIG. 4 is a graphic showing multiple sequence alignment at nucleotidelevel of the mitochondrial NADH dehydrogenase subunit 4L (NAD4L) gene(SEQ ID NOs: 49-64). All the accessions used in the study are labelled 1through 17 with gene prefix. Triticale line 343CMS is number 12.Sequence change of interest is highlighted with asterisk (*) andnucleotide position. Nucleotides 45-94 and 183-228 of SEQ ID NO: 49,nucleotides 44-93 and 182-227 of SEQ ID NO: 50, nucleotides 43-92 and181-226 of SEQ ID NO: 51, nucleotides 45-94 and 183-228 of SEQ ID NO:52, nucleotides 46-92 and 161-194 of SEQ ID NO: 53, nucleotides 49-98and 187-232 of SEQ ID NO: 54, nucleotides 45-94 and 183-228 of SEQ IDNO: 55, nucleotides 48-97 and 186-231 of SEQ ID NO: 56, nucleotides47-96 and 185-230 of SEQ ID NO: 57, nucleotides 45-94 and 183-228 of SEQID NO: 58, nucleotides 47-96 and 185-230 of SEQ ID NO: 59, nucleotides47-96 and 185-230 of SEQ ID NO: 60, nucleotides 49-98 and 187-232 of SEQID NO: 61, nucleotides 51-100 and 189-234 of SEQ ID NO: 62, nucleotides47-96 and 185-230 of SEQ ID NO: 63, and nucleotides 51-97 and 195-244 ofSEQ ID NO: 64 are shown.

DESCRIPTION

Provided here is triticale seed, a triticale plant, a triticale line anda triticale hybrid. This invention further relates to a method forproducing triticale seed and plants. All references cited in thisapplication are herein incorporated by reference.

Most of the triticale grown in the United States is used for feed grainand forage for swine, dairy cattle, and poultry. Triticale competes withother cereal grains, primarily common wheat and oats, for these foragemarkets. These markets in the U.S. are substantial. Cereal silage andhay are important in the major dairy producing regions, and cereal hayis a popular forage for horses.

Triticale is a cross between wheat as the female plant and rye as thepollinator. Compared to common wheat and oats, triticale has importantadvantages for forage production in terms of yield, production costs,and tolerance to pests, drought, low fertility, mineral toxicities, andheavy grazing. Triticale is generally superior to all classes of commonwheat for pasture, silage, hay, and for grain used for feed. Triticales,like common wheat, have either a winter or spring growth habit, but varysignificantly in plant height, tend to tiller less, and have a largerinflorescence when compared with common wheat. The majority of triticalecultivars have prominent awns, which sometimes cause problems inpastures or in hay. Certain releases are awnless and have increased itspotential use as forage.

Common wheat and triticale have many similarities in their pattern ofplant development and morphology. The flower heads or spikes, develop atthe top of the main stems and secondary stems called tillers, which areanalogous to branches. An individual plant usually has a main stem andmultiple tillers, the number of which depends on plant density, soilmoisture, nutrient supply, pest damage, seeding date, and temperature,as well as the genetics of the plant. Typically, two to four tillers perplant will develop to the point of developing a head. Each head at thetop of the stem consists of multiple spikelets, each of which consistsof multiple florets that produce pollen, ovules, and ultimately,kernels.

Triticale has many benefits to offer crop producers, livestock feeders,and for commercial use in soft-dough mixtures. Its major strength is itsversatility: it can be used for grazing, silage, feed, cover crops,straw, and even human consumption. Additionally, production of triticaleprovides environmental benefits such as erosion control and improvednutrient cycling through crop rotation. Thus, because of itsconsiderable benefits, significant plant breeding effort has beendirected towards breeding triticale.

There are numerous steps in the development of any novel, desirableplant germplasm. Plant breeding begins with the analysis and definitionof problems and weaknesses of the current germplasm, the establishmentof program goals, and the definition of specific breeding objectives.The next step is selection of germplasm that possess the traits to meetthe program goals. The goal is to combine in a single cultivar animproved combination of desirable traits from the parental germplasm. Intriticale, the important traits include by way of example, increasedyield and quality, resistance to diseases and insects, resistance todrought and heat, and improved agronomic traits.

Factors involved in the production of hybrid seed include controlledcross-pollination while limiting self-pollination, allowing sufficientpollen transfer, and retaining hybrid vigor and desirablecharacteristics in the progeny. Several methods have been proposed tolimit self-pollination (selfing) of the parental lines. These methodsinclude emasculation, chemically-induced male sterility,genetically-induced male sterility, cytoplasmic male sterility, daylength incompatibility and self-incompatibility. For example,emasculation can be achieved manually or mechanically on tomato andmaize, respectively. Emasculation is generally not applicable, however,to wheat and triticale due to flower architecture and scale(s) ofproduction.

In one aspect of the methods, an A line triticale plant has cytoplasmicmale sterility (CMS). It may be used in crosses with another malefertile line to produce hybrid progeny. B maintainer lines are providedwhich are male fertile plants of the line. In another aspect restorer(R) lines are provided. The maintainer and restorer lines are malefertile and female fertile. The CMS and maintainer lines are the sameline other than the maintainer line is male fertile. The cytoplasmiccomponent of the genome is not transferred through pollen and thus theprogeny of a cross between the maintainer and CMS line is male sterile.Hybrid seeds are produced in a cross with a restorer line that is malefertile and restores fertility to progeny.

As detailed below, a comparison of the cytoplasm of 343CMS with thegenome of 15 triticale lines showed distinct sequence changes in theknown mitochondrial genes, Atp8-1, NAD9 and NAD4L. ATP synthase producesATP from ADP. Atp8 refers to mitochondrially encoded ATP synthasemembrane subunit 8 that encodes a subunit of mitochondrial ATP synthase.It is linked to CMS in Brassica, Raphanus and sunflower. See, e.g.,Hanson et al. (2004) “Interactions of mitochondrial and nuclear genesthat affect male gametophyte development” The Plant Cell Vol. 165154-5169. NAD9 is a subunit of mitochondrial NADH dehydrogenase. SeeLamattina et al. (1993) “Higher plant mitochondria encode an homologueof the nuclear-encoded 30-kDa subunit of bovine mitochondrial complex”Eur. J. Biochem. 217, 831-838. NAD4L is a subunit of NADH dehydrogenase.It also has been associated with CMS. See Sinha et al. (2015)“Association of gene with cytoplasmic male sterility in Pigeonpea” ThePlant Genome Vol. 8, No. 2.

The comparison showed that 343CMS had changes at positions 155, 176,186, 286, 295, and 337bp of the Atp8-1 gene; changes in position 170 and338 bp of NAD9 and in NAD4L changes in positions 51, 54, 57, 89, 99,106, 159, 181, 185, 199, 220, 226, and 425 to 429 bp that differentiatedit cytoplasm from other accessions. Markers for such sequence changesallows for detection of 343CMS.

Compositions disclosed herein include polynucleotides and polypeptidesthat influence male fertility. In particular, isolated polynucleotidesare provided comprising nucleotide sequences set forth in SEQ ID NOs:32, 48, 64, 66, and 68, or active fragments or variants thereof. Furtherprovided are polypeptides having an amino acid sequence encoded by apolynucleotide described herein, for example those set forth in SEQ IDNO: 70 or 72, or active fragments or variants thereof.

Sexually reproducing plants develop specialized tissues for theproduction of male and female gametes. Successful production of malegametes relies on proper formation of the male reproductive tissues. Thestamen, which embodies the male reproductive organ of plants, containsvarious cell types, including for example, the filament, anther,tapetum, and pollen. As used herein, “male tissue” refers to thespecialized tissue in a sexually reproducing plant that is responsiblefor production of the male gamete. Male tissues include, but are notlimited to, the stamen, filament, anther, tapetum, and pollen.

The process of mature pollen grain formation begins withmicrosporogenesis, wherein meiocytes are formed in the sporogenoustissue of the anther. Microgametogenesis follows, wherein microsporenuclei undergo an asymmetric mitotic division to develop themicrogametophyte, or pollen grain. The condition of “male fertility” or“male fertile” refers to those plants producing a mature pollen graincapable of fertilizing a female gamete to produce a subsequentgeneration of offspring. The term “influences male fertility” or“modulates male fertility”, as used herein, refers to any increase ordecrease in the ability of a plant to produce a mature pollen grain whencompared to an appropriate control. A “mature pollen grain” or “maturepollen” refers to any pollen grain capable of fertilizing a femalegamete to produce a subsequent generation of offspring. Likewise, theterm “male-fertility polynucleotide” or “male-fertility polypeptide”refers to a polynucleotide or polypeptide that modulates male fertility.

Male-fertility polynucleotides disclosed herein include homologs andorthologs of polynucleotides shown to influence male fertility. Forexample, male-fertility polynucleotides, and active fragments andvariants thereof, disclosed herein include homologs and orthologs ofAtp8-1, NAD9, and NAD4L.

Fragments and variants of the disclosed polynucleotides and proteinsencoded thereby are also provided. By “fragment” is intended a portionof the polynucleotide or a portion of the amino acid sequence and henceprotein encoded thereby. Fragments of a polynucleotide may encodeprotein fragments that retain the biological activity of the nativeprotein and hence influence male fertility; these fragments may bereferred to herein as “active fragments.” Alternatively, fragments of apolynucleotide that are useful as hybridization probes or which areuseful in constructs and strategies for down-regulation or targetedsequence modification generally do not encode protein fragmentsretaining biological activity, but may still influence male fertility.Thus, fragments of a nucleotide sequence may range from at least about20 nucleotides, about 50 nucleotides, about 100 nucleotides, up to thefull-length polynucleotide encoding a polypeptide disclosed herein.

A fragment of a polynucleotide that encodes a biologically activeportion of a polypeptide that influences male fertility will encode atleast 15, 25, 30, 50, 100, 150, or 200 contiguous amino acids, or up tothe total number of amino acids present in a full-length polypeptidethat influences male fertility. Fragments of a male-fertilitypolynucleotide that are useful as hybridization probes or PCR primers,or in a down-regulation construct or targeted-modification methodgenerally need not encode a biologically active portion of a polypeptidebut may influence male fertility.

Thus, a fragment of a male-fertility polynucleotide as disclosed hereinmay encode a biologically active portion of a male-fertilitypolypeptide, or it may be a fragment that can be used as a hybridizationprobe or PCR primer or in a downregulation construct ortargeted-modification method using methods known in the art or disclosedbelow. A biologically active portion of a male-fertility polypeptide canbe prepared by isolating a portion of one of the male-fertilitypolynucleotides disclosed herein, expressing the encoded portion of themale-fertility protein (e.g., by recombinant expression in vitro), andassessing the activity of the encoded portion of the male-fertilitypolypeptide. Polynucleotides that are fragments of a male-fertilitypolynucleotide comprise at least 16, 20, 50, 75, 100, 150, 200, 250,300, 350, 400, 450, 500, 550, 600, 650, 700, 800, 900, 1000, 1200, 1400,1600, 1800, 2000, 2200, 2400, 2600, 2800, 3000, 3200, 3400, 3600, 3800,or 4000 nucleotides, or up to the number of nucleotides present in afull-length male-fertility polynucleotide disclosed herein.

“Variants” is intended to mean substantially similar sequences. Forpolynucleotides, a variant comprises a deletion and/or addition of oneor more nucleotides at one or more sites within the nativepolynucleotide and/or a substitution of one or more nucleotides at oneor more sites in the native polynucleotide. As used herein, a “native”or “wild type” polynucleotide or polypeptide comprises a naturallyoccurring nucleotide sequence or amino acid sequence, respectively. Forpolynucleotides, conservative variants include those sequences that,because of the degeneracy of the genetic code, encode the amino acidsequence of a male-fertility polypeptide disclosed herein. Naturallyoccurring allelic variants such as these can be identified with the useof well-known molecular biology techniques, as, for example, withpolymerase chain reaction (PCR) and hybridization techniques as outlinedbelow. Variant polynucleotides also include synthetically derivedpolynucleotides, such as those generated, for example, by usingsite-directed mutagenesis, and which may encode a male-fertilitypolypeptide. Generally, variants of a particular polynucleotidedisclosed herein will have at least about 40%, 45%, 50%, 55%, 60%, 65%,70%, 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%,96%, 97%, 98%, 99% or more sequence identity to that particularpolynucleotide as determined by sequence alignment programs andparameters described elsewhere herein or known in the art.

Variants of a particular polynucleotide disclosed herein (i.e., areference polynucleotide) can also be evaluated by comparison of thepercent sequence identity between the polypeptide encoded by a variantpolynucleotide and the polypeptide encoded by the referencepolynucleotide. Thus, for example, an isolated polynucleotide may encodea polypeptide with a given percent sequence identity to the polypeptideof SEQ ID NO: 70 or 72. Percent sequence identity between any twopolypeptides can be calculated using sequence alignment programs andparameters described elsewhere herein. Where any given pair ofpolynucleotides disclosed herein is evaluated by comparison of thepercent sequence identity shared by the two polypeptides they encode,the percent sequence identity between the two encoded polypeptides is atleast about 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 86%, 87%,88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or moresequence identity.

“Variant” protein is intended to mean a protein derived from the nativeprotein by deletion or addition of one or more amino acids at one ormore sites in the native protein and/or substitution of one or moreamino acids at one or more sites in the native protein. Variant proteinsdisclosed herein are biologically active, that is they continue topossess biological activity of the native protein, that is, malefertility activity as described herein. Such variants may result from,for example, genetic polymorphism or human manipulation. Biologicallyactive variants of a male-fertility protein disclosed herein will haveat least about 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 86%,87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or moresequence identity to the amino acid sequence for the native protein asdetermined by sequence alignment programs and parameters describedelsewhere herein or known in the art. A biologically active variant of aprotein disclosed herein may differ from that protein by as few as 1-15amino acid residues, as few as 1-10, such as 6-10, as few as 5, as fewas 4, 3, 2, or even 1 amino acid residue.

The proteins disclosed herein may be altered in various ways includingamino acid substitutions, deletions, truncations, and insertions.Methods for such manipulations are generally known in the art. Forexample, amino acid sequence variants and fragments of themale-fertility polypeptides can be prepared by mutations in the DNA.Methods for mutagenesis and polynucleotide alterations are well known inthe art. See, for example, Kunkel (1985) Proc. Natl. Acad. Sci. USA82:488-492; Kunkel et al. (1987) Methods in Enzymol. 154:367-382; U.S.Pat. No. 4,873,192; Walker and Gaastra, eds. (1983) Techniques inMolecular Biology (MacMillan Publishing Company, New York) and thereferences cited therein. Guidance as to appropriate amino acidsubstitutions that do not affect biological activity of the protein ofinterest may be found in the model of Dayhoff et al. (1978) Atlas ofProtein Sequence and Structure (Natl. Biomed. Res. Found., Washington,D.C.), herein incorporated by reference. Conservative substitutions,such as exchanging one amino acid with another having similarproperties, may be optimal.

Thus, the genes and polynucleotides disclosed herein include both thenaturally occurring sequences as well as DNA sequence variants.Likewise, the male-fertility polypeptides and proteins encompass bothnaturally occurring polypeptides as well as variations and modifiedforms thereof. Such polynucleotide and polypeptide variants may continueto possess the desired male-fertility activity, in which case themutations that will be made in the DNA encoding the variant must notplace the sequence out of reading frame and optimally will not createcomplementary regions that could produce secondary mRNA structure. See,EP Patent Application Publication No. 75,444.

Certain deletions, insertions, and substitutions of the proteinsequences encompassed herein are not expected to produce radical changesin the characteristics of the protein. However, when it is difficult topredict the exact effect of the substitution, deletion, or insertion inadvance of doing so, one skilled in the art will appreciate that theeffect will be evaluated by routine screening assays. That is, theactivity can be evaluated by assaying for male fertility activity.

Increases or decreases in male fertility can be assayed in a variety ofways. One of ordinary skill in the art can readily assess activity ofthe variant or fragment by introducing the polynucleotide into a planthomozygous for a stable male-sterile allele of the polynucleotide, andobserving male tissue development in the plant.

Variant functional polynucleotides and proteins also encompass sequencesand proteins derived from a mutagenic and recombinogenic procedure suchas DNA shuffling. With such a procedure, one or more different malefertility sequences can be manipulated to create a new male-fertilitypolypeptide possessing desired properties. In this manner, libraries ofrecombinant polynucleotides are generated from a population of relatedsequence polynucleotides comprising sequence regions that havesubstantial sequence identity and can be homologously recombined invitro or in vivo. For example, using this approach, sequence motifsencoding a domain of interest may be shuffled between the male-fertilitypolynucleotides disclosed herein and other known male-fertilitypolynucleotides to obtain a new gene coding for a protein with animproved property of interest, such as an increased K_(m) in the case ofan enzyme. Strategies for such DNA shuffling are known in the art. See,for example, Stemmer (1994) Proc. Natl. Acad. Sci. USA 91:10747-10751;Stemmer (1994) Nature 370:389-391; Crameri et al. (1997) Nature Biotech.15:436-438; Moore et al. (1997) J. Mol. Biol. 272:336-347; Zhang et al.(1997) Proc. Natl. Acad. Sci. USA 94:4504-4509; Crameri et al. (1998)Nature 391:288-291; and U.S. Pat. Nos. 5,605,793 and 5,837,458.

As used herein, “sequence identity” or “identity” in the context of twopolynucleotide or polypeptide sequences makes reference to the residuesin the two sequences that are the same when aligned for maximumcorrespondence over a specified comparison window. When percentage ofsequence identity is used in reference to proteins, it is recognizedthat residue positions which are not identical often differ byconservative amino acid substitutions, where amino acid residues aresubstituted for other amino acid residues with similar chemicalproperties (e.g., charge or hydrophobicity) and therefore do not changethe functional properties of the molecule. When sequences differ inconservative substitutions, the percent sequence identity may beadjusted upwards to correct for the conservative nature of thesubstitution. Sequences that differ by such conservative substitutionsare said to have “sequence similarity” or “similarity”. Means for makingthis adjustment are well known to those of skill in the art. Typicallythis involves scoring a conservative substitution as a partial ratherthan a full mismatch, thereby increasing the percentage sequenceidentity. Thus, for example, where an identical amino acid is given ascore of 1 and a non-conservative substitution is given a score of zero,a conservative substitution is given a score between zero and 1. Thescoring of conservative substitutions is calculated, e.g., asimplemented in the program PC/GENE (Intelligenetics, Mountain View,Calif.).

As used herein, “percentage of sequence identity” means the valuedetermined by comparing two optimally aligned sequences over acomparison window, wherein the portion of the polynucleotide sequence inthe comparison window may comprise additions or deletions (i.e., gaps)as compared to the reference sequence (which does not comprise additionsor deletions) for optimal alignment of the two sequences. The percentageis calculated by determining the number of positions at which theidentical nucleic acid base or amino acid residue occurs in bothsequences to yield the number of matched positions, dividing the numberof matched positions by the total number of positions in the window ofcomparison, and multiplying the result by 100 to yield the percentage ofsequence identity.

Unless otherwise stated, sequence identity/similarity values providedherein refer to the value obtained using GAP Version 10 using thefollowing parameters: % identity and % similarity for a nucleotidesequence using GAP Weight of 50 and Length Weight of 3, and thenwsgapdna.cmp scoring matrix; % identity and % similarity for an aminoacid sequence using GAP Weight of 8 and Length Weight of 2, and theBLOSUM62 scoring matrix; or any equivalent program thereof. By“equivalent program” is intended any sequence comparison program that,for any two sequences in question, generates an alignment havingidentical nucleotide or amino acid residue matches and an identicalpercent sequence identity when compared to the corresponding alignmentgenerated by GAP Version 10.

A person of skill in the art appreciates there are a variety of methodsto produce markers that allow for identification of the distinguishingsequences changes. Markers that detect genetic polymorphisms betweenmembers of a population are well-established in the art. Markers can bedefined by the type of polymorphism that they detect and also the markertechnology used to detect the polymorphism. Marker types include but arenot limited to, e.g., detection of restriction fragment lengthpolymorphisms (RFLP), detection of isozyme markers, randomly amplifiedpolymorphic DNA (RAPD), amplified fragment length polymorphisms (AFLPs),detection of simple sequence repeats (SSRs), detection of amplifiedvariable sequences of the plant genome, detection of self-sustainedsequence replication, or detection of single nucleotide polymorphisms(SNPs). SNPs can be detected eg via DNA sequencing, PCR-based sequencespecific amplification methods, detection of polynucleotidepolymorphisms by allele specific hybridization (ASH), dynamicallele-specific hybridization (DASH), Competitive (Kompetitive)Allele-Specific Polymerase chain reaction (KASPar), molecular beacons,microarray hybridization, oligonucleotide ligase assays, Flapendonucleases, 5′ endonucleases, primer extension, single strandconformation polymorphism (SSCP) or temperature gradient gelelectrophoresis (TGGE). DNA sequencing, such as the pyrosequencingtechnology have the advantage of being able to detect a series of linkedSNP alleles that constitute a haplotype. Haplotypes tend to be moreinformative (detect a higher level of polymorphism) than SNPs.

One such method is to use KASP system. The process uses an assay mix ofthree assay-specific oligonucleotides, including two alleles specificforward primers and one common reverse primer. The allele-specificprimers have a unique tail sequence corresponding with a universalfluorescence resonant energy transfer cassette (FRET) where one islabeled with a dye (FAM™) and the other with a different dye (HEX™). Amaster mix has the universal FRET cassettes, a passive reference dye(ROX™) and TAQ polymerase. The allele-specific primer binds andelongates the template during thermal cycling which includes the tail inthe produced strand. When the complement of the tail sequence isproduced in subsequent PCR rounds the FRET cassette can bind to the DNA.Since the FRET cassette is no longer quenched it will fluoresce. Ahomozygous SNP presence will produce one of the fluorescent signals, ifit is heterozygous, a mixed fluorescent signal is produced.

Producing primers and probes that amplify or detect the presence of asequence can be readily accomplished by a person of skill in the art. Ina PCR approach, oligonucleotide primers can be designed for use in PCRreactions to amplify corresponding DNA sequences from cDNA or genomicDNA extracted from any plant of interest. Methods for designing PCRprimers and PCR cloning are generally known in the art and are disclosed(Sambrook, J., Fritsch, E. F. and Maniatis, T. (2001) Molecular Cloning:A Laboratory Manual, 3rd Edition. Cold Spring Harbor Laboratory Press,Plainview, N. Y; Innis, M., Gelfand, D. and Sninsky, J. (1995) PCRStrategies. Academic Press, New York; Innis, M., Gelfand, D. andSninsky, J. (1999) PCR Applications: Protocols for Functional Genomics,Academic Press, New York. Indeed, computer programs can determineprimers that hybridize with targeted sequences.

By way of further example, without limitation, hybridization probes maybe genomic DNA fragments, cDNA fragments, RNA fragments, or otheroligonucleotides, and may be labeled with a detectable group such as32P, or any other detectable marker. Thus, for example, probes forhybridization can be made by labeling synthetic oligonucleotides basedon the DNA sequences. Methods for preparation of probes forhybridization and for construction of cDNA and genomic libraries aregenerally known in the art and are disclosed (Sambrook et al., (2001)Molecular Cloning: A Laboratory Manual (3^(rd) ed., Cold Spring HarborLaboratory Press, Plainview, N.Y.). For example, the sequence disclosedherein, or one or more portions thereof, may be used as a probe capableof specifically hybridizing to corresponding sequences. To achievespecific hybridization under a variety of conditions, such probesinclude sequences that are unique among the sequences to be screened andcan be at least about 10 nucleotides in length, and can be at leastabout 20 nucleotides in length. Such sequences may alternatively be usedto amplify corresponding sequences from a chosen plant by PCR. Thistechnique may be used to isolate sequences from a desired plant or as adiagnostic assay to determine the presence of sequences in a plant.Hybridization techniques include hybridization screening of DNAlibraries plated as either plaques or colonies (Sambrook et al., 2001).

It will be evident to one of skill in the art that the above sequencesmay be introduced into a plant not comprising the sequences, usingtechniques such as those described herein.

When producing a line or variety, choice of breeding or selectionmethods depends on the mode of plant reproduction, the heritability ofthe trait(s) being improved, and the type of cultivar used commercially(e.g., F₁ hybrid cultivar, pureline cultivar, etc.). Popular selectionmethods commonly include pedigree selection, modified pedigreeselection, mass selection, and recurrent selection.

The goal of a commercial triticale breeding program is to develop new,unique and superior triticale cultivars. The breeder initially selectsand crosses two or more parental lines, followed by generationadvancement and selection, thus producing many new genetic combinations.The breeder can theoretically generate billions of different geneticcombinations via this procedure. The breeder has no direct control overwhich genetic combinations will arise in the limited population sizewhich is grown. Therefore, two breeders will never develop the same linehaving the same traits.

Each year, the plant breeder selects the germplasm to advance to thenext generation. This germplasm is grown under unique and differentgeographical, climatic and soil conditions, and further selections arethen made, during and at the end of the growing season. The lines whichare developed are unpredictable. This unpredictability is because thebreeder's selection occurs in unique environments, with no control atthe DNA level (using conventional breeding procedures), and withmillions of different possible genetic combinations being generated. Abreeder of ordinary skill in the art cannot predict the final resultinglines he develops, except possibly in a very gross and general fashion.The same breeder cannot produce, with any reasonable likelihood, thesame cultivar twice by using the exact same original parents and thesame selection techniques. This unpredictability results in theexpenditure of large amounts of research moneys to develop superior newtriticale cultivars.

Pureline cultivars of triticale are commonly bred by hybridization oftwo or more parents followed by selection. The complexity ofinheritance, the breeding objectives and the available resourcesinfluence the breeding method. Pedigree breeding, recurrent selectionbreeding and backcross breeding are breeding methods commonly used inself-pollinated crops such as triticale. These methods refer to themanner in which breeding pools or populations are made in order tocombine desirable traits from two or more cultivars or variousbroad-based sources. The procedures commonly used for selection ofdesirable individuals or populations of individuals are called massselection, plant-to-row selection and single seed descent or modifiedsingle seed descent. One, or a combination of these selection methods,can be used in the development of a cultivar from a breeding population.

Pedigree breeding is primarily used to combine favorable genes into atotally new cultivar that is different in many traits than either parentused in the original cross. It is commonly used for the improvement ofself-pollinating crops. Two parents which possess favorable,complementary traits are crossed to produce an F (filial generation 1).An F₂ population is produced by selfing F₁ plants. Selection ofdesirable individual plants may begin as early as the F₂ generationwherein maximum gene segregation occurs. Individual plant selection canoccur for one or more generations. Successively, seed from each selectedplant can be planted in individual, identified rows or hills, known asprogeny rows or progeny hills, to evaluate the line and to increase theseed quantity, or, to further select individual plants. Once a progenyrow or progeny hill is selected as having desirable traits it becomeswhat is known as a breeding line that is specifically identifiable fromother breeding lines that were derived from the same originalpopulation. At an advanced generation (i.e., F₅ or higher) seed ofindividual lines are evaluated in replicated testing. At an advancedstage the best lines or a mixture of phenotypically similar lines fromthe same original cross are tested for potential release as newcultivars.

One method of breeding utilizes the single seed descent procedure whichthe strict sense refers to planting a segregating population, harvestingone seed from every plant, and combining these seeds into a bulk whichis planted the next generation. When the population has been advanced tothe desired level of inbreeding, the plants from which lines are derivedwill each trace to different F₂ individuals. Primary advantages of theseed descent procedures are to delay selection until a high level ofhomozygosity (e.g., lack of gene segregation) is achieved in individualplants, and to move through these early generations quickly, usuallythrough using off-season nurseries.

Selection for desirable traits can occur at any segregating generation(F₂ and above). Selection pressure is exerted on a population by growingthe population in an environment where the desired trait is maximallyexpressed and the individuals or lines possessing the trait can beidentified. For instance, selection can occur for disease resistancewhen the plants or lines are grown in natural or artificially-induceddisease environments, and the breeder selects only those individualshaving little or no disease and are thus assumed to be resistant.

In addition to phenotypic observations, the genotype of a plant can alsobe examined. There are many laboratory-based techniques available forthe analysis, comparison and characterization of plant genotype; amongthese are Isozyme Electrophoresis, Restriction Fragment LengthPolymorphisms (RFLPs), Randomly Amplified Polymorphic DNAs (RAPDs),Arbitrarily Primed Polymerase Chain Reaction (AP-PCR), DNA AmplificationFingerprinting (DAF), Sequence Characterized Amplified Regions (SCARs),Amplified Fragment Length polymorphisms (AFLPs), Simple Sequence Repeats(SSRs—which are also referred to as Microsatellites), and SingleNucleotide Polymorphisms (SNPs). Such techniques are described furthersupra.

Molecular markers, which include markers identified through the use oftechniques such as Starch Gel Electrophoresis, Isozyme Electrophoresis,RFLPs, RAPDs, AP-PCR, DAF, SCARs, AFLPs, SSRs, and SNPs, may be used inplant breeding. One use of molecular markers is Quantitative Trait Loci(QTL) mapping. QTL mapping is the use of markers which are known to beclosely linked to alleles that have measurable effects on a quantitativetrait. Selection in the breeding process is based upon the accumulationof markers linked to the positive effecting alleles and/or theelimination of the markers linked to the negative effecting alleles fromthe plant's genome.

Molecular markers can also be used during the breeding process for theselection of qualitative traits. For example, markers closely linked toalleles or markers containing sequences within the actual alleles ofinterest can be used to select plants that contain the alleles ofinterest during a backcrossing breeding program. For example, molecularmarkers are used in soybean breeding for selection of the trait ofresistance to soybean cyst nematode, see U.S. Pat. No. 6,162,967. Themarkers can also be used to select toward the genome of the recurrentparent and against the markers of the donor parent. Using this procedurecan attempt to minimize the amount of genome from the donor parent thatremains in the selected plants. It can also be used to reduce the numberof crosses back to the recurrent parent needed in a backcrossingprogram. The use of molecular markers in the selection process is oftencalled Genetic Marker Enhanced Selection. Molecular markers may also beused to identify and exclude certain sources of germplasm as parentalvarieties or ancestors of a plant by providing a means of trackinggenetic profiles through crosses as discussed more fully hereinafter.

Mutation breeding is another method of introducing new traits intotriticale varieties. Mutations that occur spontaneously or areartificially induced can be useful sources of variability for a plantbreeder. The goal of artificial mutagenesis is to increase the rate ofmutation for a desired characteristic. Mutation rates can be increasedby many different means including temperature, long-term seed storage,tissue culture conditions, radiation (such as X-rays, Gamma rays,neutrons, Beta radiation, or ultraviolet radiation), chemical mutagens(such as base analogues like 5-bromo-uracil), antibiotics, alkylatingagents (such as sulfur mustards, nitrogen mustards, epoxides,ethyleneamines, sulfates, sulfonates, sulfones, or lactones), azide,hydroxylamine, nitrous acid or acridines. Once a desired trait isobserved through mutagenesis the trait may then be incorporated intoexisting germplasm by traditional breeding techniques. Details ofmutation breeding can be found in “Principles of Cultivar Development”by Fehr, Macmillan Publishing Company, 1993.

The production of double haploids can also be used for the developmentof homozygous varieties in a breeding program. Double haploids areproduced by the doubling of a set of chromosomes from a heterozygousplant to produce a completely homozygous individual. For example, seeWan et al., Theor. Appl. Genet., 77:889-892, 1989.

Descriptions of other breeding methods that are commonly used fordifferent traits and crops can be found in one of several referencebooks (e.g., Allard, 1960; Simmonds, 1979; Sneep, et al. 1979; Fehr,1987).

Triticale is an important and valuable field crop. Thus, a continuinggoal of triticale plant breeders is to develop stable, high yieldingtriticale cultivars that are agronomically sound. The reasons for thisgoal are to maximize yield and the quality of the final product forforage, silage, and human consumption. To accomplish this goal, thetriticale breeder must select and develop plants that have the traitsthat result in superior cultivars. The development of new triticalecultivars requires the evaluation and selection of parents and thecrossing of these parents. The lack of predictable success of a givencross requires that a breeder, in any given year, make several crosseswith the same or different breeding objectives.

The foregoing examples of the related art and limitations relatedtherewith are intended to be illustrative and not exclusive. Otherlimitations of the related art will become apparent to those of skill inthe art upon a reading of the specification. References cited herein areincorporated herein by reference.

In the description and tables which follow, a number of terms are used.In order to provide a clear and consistent understanding of thespecification and claims, including the scope to be given such terms,the following definitions are provided:

Allele. Allele is any of one or more alternative forms of a gene, all ofwhich alleles relate to one trait or characteristic. In a diploid cellor organism, the two alleles of a given gene occupy corresponding locion a pair of homologous chromosomes.

Awn. Awn is intended to mean the elongated needle-like appendages on theflower and seed-bearing “head” at the top of the cereal grain plant(e.g., triticale, common wheat, rye). These awns are attached to thelemmas. Lemmas enclose the stamen and the stigma as part of the florets.These florets are grouped in spikelets, which in turn together comprisethe head.

Backcrossing. Backcrossing is a process in which a breeder repeatedlycrosses hybrid progeny back to one of the parents, for example, a firstgeneration hybrid F₁ with one of the parental genotypes of the F₁hybrid.

Disease Resistance. As used herein, the term “disease resistance” isdefined as the ability of plants to restrict the activities of aspecified pest or pathogen, such as an insect, fungus, virus, orbacterial.

Disease Tolerance. As used herein, the term “disease tolerance” isdefined as the ability of plants to endure a specified pest or pathogen(such as an insect, fungus, virus or bacteria) or an adverseenvironmental condition and still perform and produce in spite of thisdisorder.

Essentially all of the physiological and morphological characteristics.A plant having essentially all of the physiological and morphologicalcharacteristics means a plant having the physiological and morphologicalcharacteristics of the recurrent parent, except for the characteristicsderived from the converted trait.

Head. As used herein, the term “head” refers to a group of spikelets atthe top of one plant stem. The term “spike” also refers to the head of aplant located at the top of one plant stem.

Maturity. As used herein, the term “maturity” refers to the stage ofplant growth at which the development of the kernels is complete.

As used herein, the term plant includes reference to an immature ormature whole plant, including a plant from which seed, grain, or anthershave been removed. A seed or embryo that will produce the plant is alsoconsidered to be a plant. Reference to a plant is used broadly herein toinclude any plant at any stage of development.

A plant part refers to any part of a plant, including a plant cutting, aplant cell, a plant cell culture, a plant organ, a plant seed, and aplantlet. Examples include, without limitation, protoplasts, callus,leaves, stems, roots, root tips, anthers, pistils, seed, grain,pericarp, embryo, pollen, ovules, cotyledon, hypocotyl, spike, floret,awn, lemma, shoot, tissue, petiole, cells, and meristematic cells. Aplant cell is the structural and physiological unit of the plant,comprising a protoplast and a cell wall. A plant cell can be in the formof an isolated single cell or aggregate of cells such as a friablecallus, or a cultured cell, or can be part of a higher organized unit,for example, a plant tissue, plant organ, or plant. Thus, a plant cellcan be a protoplast, a gamete producing cell, or a cell or collection ofcells that can regenerate into a whole plant. A plant part includesplant tissue or any other groups of plant cells that is organized into astructural or functional unit.

Plant Height (Hgt). As used herein, the term “plant height” is definedas the average height in inches or centimeters of a group of plants.

Stripe Rust. A disease of triticale, common wheat, durum wheat, andbarley characterized by elongated rows of yellow spores on the affectedparts, caused by a rust fungus, Puccinia striiformis.

Single Trait Converted (Conversion). Single trait converted (conversion)plant refers to plants which are developed by a plant breeding techniquecalled backcrossing or via genetic engineering wherein essentially allof the desired morphological and physiological characteristics of avariety are recovered in addition to the single trait transferred intothe variety via the backcrossing technique or via genetic engineering.

343CMS

343CMS is a cytoplasmic male sterile (CMS) facultative, awned, semidwarfhexaploidy triticale. The variety is CMS stable and sterile. 343CMS (andits maintainer line 3-4-4) is a medium tall triticale ranging in plantheight from 32-42″ depending upon the environment. It is a facultativetriticale with good enough winterhardiness to survive Kansas winterconditions but capable of being planted as a spring type. It is mediumearly in maturity. 343CMS is awned. At maturity it has black awns andpurple seed. It is resistant to local races of stripe rust in Kansas butsusceptible to local races of leaf rust. 343CMS (and its maintainer line3-4-4) has been stable since 2012. Less than 0.1% of the plants wererogued from the Breeder seed increase in 2017. Approximately 80% of thevariant plants were taller height plants and approximately 20% wereawnletted plants. Up to 1.0% variant plants may be encountered insubsequent generations.

343CSM has been selected for uniform and stable sterility, significantlyimproved outcrossing ability and flexibility to be planted both in thewinter and spring environments. It is a medium plant height, mediumearly triticale that has resistance to stripe rust but is susceptible toleaf rust.

The variety is uniform, has stable sterility and significantly improvedoutcrossing ability and flexibility. It has been tested for uniformityand stability for five years growth. Up to 1% variant plants can beobserved or expected during reproduction and multiplication. Expressionof both black awns and purple seed is affected by cooler night timetemperatures during grain filling. Cooler temperatures at night increasethe expression of both traits. 343CMS is maintained by a fertilemaintainer line (3-4-4) which contains a normal Durum cytoplasm and isself-fertile. Both 343CMS and 3-4-4 are identical in phenotype and havebeen stable and uniform for 5 years.

343CMS can be produced using 3-4-4 as a male donator of pollen. Ratiosused to produce the CMS sterile 343CMS will generally be three parts343CMS and one part fertile and pollen producing 3-4-4 planted in astrip planting design. 3-4-4 is derived from the cross BX 10356 whichwas the combination of 3 experimental selections. 343CMS has beenback-crossed (maintained) by 3-4-4 for 8 generations (BC8).

The following is a botanical description of the new variety of triticalebased on observations of various specimens grown in Junction City,Kans., Yuma, Ariz., Bozeman, Mont., and Moses Lake, Wash.

TABLE 1 Growth Habit Spring/intermediate/winterSpring/intermediate/winter Juvenile plant growth Semi-prostratePhotoperiod Insensitive Use Dual grain, feed and forage PloidyHexaploid, 42 2n chromosome number Maturity Early, same as PVP 946802617Height Mid-tall, same as PVP 946802617 Plant color at boot stage GreenStem Anthocyanin Absent Neck hairiness Moderate Shape of neck StraightLeaves Flag leaf Not twisted Waxy bloom on leaf at boot Absent Leafcarriage Recurved Leaf length 28 cm (1^(st) leaf below flag leaf) leafwidth 1.5 mm (1^(st) leaf below flag leaf) Auricle color Purple HeadDensity Mid-dense Shape Oblong Awnedness Awned Awn color Tan Head length10 cm Head width 15 mm Glumes at maturity Pubescence Slightly pubescentColor Tan Length Mid-long Width Mid-wide Shoulder Oblique ApiculateObtuse Coleoptile color Purple Seed Shape Oval Smoothness Slightlywrinkled Brush area Large Brush length Long Color Purple GMS per 1,000seed 35 Disease Stripe Rust Resistant to Kansas races Powdery mildewResistant Septoria Susceptible Leaf rust Susceptible Ergot SusceptibleBacterial stripe Susceptible

343CMS is most similar to variety PVP 946802617, in plant tillering,winter hardiness, area of adaptation and seed shape. In qualitativetraits, winter hardiness was tested in Kansas. 343CMS survived thewinters in Kansas. Seed of 343CMS was purple in color, where seed of PVP946802617 was tan.

This invention is also directed to methods for producing a triticaleplant by crossing a first parent triticale plant with a second parenttriticale plant, wherein the first or second triticale plant is thetriticale plant from the cultivar 343CMS. Further, the first or secondparent may be a common wheat cultivar. Therefore, any methods using thecultivar 343CMS are part of this invention: backcrosses, hybridbreeding, and crosses to populations. Any plants produced using cultivar343CMS as a parent are within the scope of this invention. As usedherein, the term “plant” includes plant cells, plant protoplasts, plantcells of tissue culture from which triticale plants can be regenerated,plant calli, plant clumps, and plant cells that are intact in plants orparts of plants, such as pollen, flowers, embryos, ovules, seeds,leaves, stems, roots, anthers and the like. Thus, another aspect of thisinvention is to provide for cells which upon growth and differentiationproduce a cultivar having essentially all of the physiological andmorphological characteristics of 343CMS.

The present compositions and methods contemplate a triticale plantregenerated from a tissue culture of a cultivar (e.g., 343CMS) or hybridplant of the present invention. As is well known in the art, tissueculture of triticale can be used for the in vitro regeneration of atriticale plant. Tissue culture of various tissues of plants andregeneration of plants therefrom is well known and widely published.

Further Embodiments and Methods

With the advent of molecular biological techniques that have allowed theisolation and characterization of genes that encode specific proteinproducts, scientists in the field of plant biology developed a stronginterest in engineering the genome of plants to contain and expressforeign genes, or additional, or modified versions of native, orendogenous, genes (perhaps driven by different promoters) in order toalter the traits of a plant in a specific manner. Such foreignadditional and/or modified genes are referred to herein collectively as“transgenes”. Many methods for producing transgenic plants have beendeveloped, and the present invention, in particular embodiments, alsorelates to transformed versions of the claimed cultivar.

When referring to a transgene is meant to include a heterologous nucleicacid molecule which may be a heterologous polynucleotide or aheterologous nucleic acid or an exogenous DNA and includes apolynucleotide, nucleic acid or DNA segment that originates from asource foreign to the particular host cell, or, if from the same source,is modified from its original form in composition and/or genomic locusby human intervention. When referring to a gene or transgene that may beintroduced into the plant is intended to include portions of the gene,and it may not include the entire gene, and may not include the nativepromoter or other components. By way of example without limitation, itcan include sequences that are duplicates of those already in the plantcell, may be a modified version of the sequence, or its expression orfunction modified. A heterologous gene in a host cell includes a genethat is endogenous to the particular host cell, but has been modified orintroduced into the plant. Thus, the terms refer to a DNA segment whichis foreign or heterologous to the cell, or homologous to the cell but ina position within the host cell nucleic acid in which the element is notordinarily found. Exogenous DNA segments are expressed to yieldexogenous polypeptides. As noted, a heterologous nucleic acid moleculemay be introduced into the plant by any convenient methods. In oneembodiment the heterologous nucleic acid molecule may be a transgenethat is introduced by transformation.

The term introduced in the context of inserting a nucleic acid orpolypeptide into a cell, includes transfection or transformation ortransduction and includes reference to the incorporation of a nucleicacid into a cell where the nucleic acid may be incorporated into thegenome of the cell (e.g., chromosome, plasmid, plastid or mitochondrialDNA), converted into an autonomous replicon, or transiently expressed(e.g., transfected mRNA). When referring to introduction of a nucleicacid sequence into a plant is meant to include transformation into thecell, as well as crossing a plant having the sequence with anotherplant, so that the second plant contains the heterologous sequence ortransgene, as in conventional plant breeding techniques. Such breedingtechniques are well known to one skilled in the art and examples arediscussed herein. For a discussion of plant breeding techniques, seePoehlman (1995) Breeding Field Crops. AVI Publication Co., WestportConn., 4th Edit. Backcrossing methods may be used to introduce a geneinto the plants. This technique has been used for decades to introducetraits into a plant. An example of a description of this and other plantbreeding methodologies that are well known can be found in referencessuch as Poehlman, supra, and Plant Breeding Methodology, edit. NealJensen, John Wiley & Sons, Inc. (1988). In a typical backcross protocol,the original variety of interest (recurrent parent) is crossed to asecond variety (nonrecurrent parent) that carries the single gene ofinterest to be transferred. The resulting progeny from this cross arethen crossed again to the recurrent parent and the process is repeateduntil a plant is obtained wherein essentially all of the desiredmorphological and physiological characteristics of the recurrent parentare recovered in the converted plant, in addition to the singletransferred gene from the nonrecurrent parent. Examples of suchtechniques and variations are set forth in further detail herein.

Various genetic elements can be introduced into the plant genome usingtransformation. These elements include, but are not limited to genes,coding sequences, inducible, constitutive, and tissue-specificpromoters, enhancing sequences, and signal and targeting sequences.

In some embodiments, the invention comprises a CMS343 plant that hasbeen developed using both genetic engineering and traditional breedingtechniques. For example, a genetic trait may have been engineered intothe genome of a particular wheat plant may then be moved into the genomeof a CMS343 plant using traditional breeding techniques that are wellknown in the plant breeding arts. Likewise, a genetic trait that hasbeen engineered into the genome of a CMS343 wheat plant may then bemoved into the genome of another cultivar using traditional breedingtechniques that are well known in the plant breeding arts. Abackcrossing approach is commonly used to move a transgene or transgenesfrom a transformed wheat cultivar into an already developed wheatcultivar, and the resulting backcross conversion plant would thencomprise the transgene(s).

Plant transformation involves the construction of an expression vectorwhich will function in plant cells. Such a vector comprises DNAcomprising a gene under control of or operatively linked to a regulatoryelement (for example, a promoter). The expression vector may contain oneor more such operably linked gene/regulatory element combinations. Thevector(s) may be in the form of a plasmid, and can be used alone or incombination with other plasmids, to provide transformed triticaleplants, using transformation methods as described below to incorporatetransgenes into the genetic material of the triticale plant(s).

Expression Cassettes

A male-fertility polynucleotide disclosed herein can be provided in anexpression cassette for expression in an organism of interest. Thecassette can include 5′ and 3′ regulatory sequences operably linked to amale-fertility polynucleotide as disclosed herein. “Operably linked” isintended to mean a functional linkage between two or more elements. Forexample, an operable linkage between a polynucleotide of interest and aregulatory sequence (e.g., a promoter) is a functional link that allowsfor expression of the polynucleotide of interest. Operably linkedelements may be contiguous or non-contiguous. When used to refer to thejoining of two protein coding regions, by operably linked is intendedthat the coding regions are in the same reading frame.

The expression cassettes disclosed herein may include in the 5′-3′direction of transcription, a transcriptional and translationalinitiation region (i.e., a promoter), a polynucleotide of interest, anda transcriptional and translational termination region (i.e.,termination region) functional in the host cell (e.g., a plant cell).Expression cassettes are also provided with a plurality of restrictionsites and/or recombination sites for insertion of the male-fertilitypolynucleotide to be under the transcriptional regulation of theregulatory regions described elsewhere herein. The regulatory regions(i.e., promoters, transcriptional regulatory regions, and translationaltermination regions) and/or the polynucleotide of interest may benative/analogous to the host cell or to each other. Alternatively, theregulatory regions and/or the polynucleotide of interest may beheterologous to the host cell or to each other. As used herein,“heterologous” in reference to a polynucleotide or polypeptide sequenceis a sequence that originates from a foreign species, or, if from thesame species, is substantially modified from its native form incomposition and/or genomic locus by deliberate human intervention. Forexample, a promoter operably linked to a heterologous polynucleotide isfrom a species different from the species from which the polynucleotidewas derived, or, if from the same/analogous species, one or both aresubstantially modified from their original form and/or genomic locus, orthe promoter is not the native promoter for the operably linkedpolynucleotide. As used herein, unless otherwise specified, a chimericpolynucleotide comprises a coding sequence operably linked to atranscription initiation region that is heterologous to the codingsequence.

In certain embodiments the polynucleotides disclosed herein can bestacked with any combination of polynucleotide sequences of interest orexpression cassettes as disclosed elsewhere herein or known in the art.For example, the male-fertility polynucleotides disclosed herein may bestacked with any other polynucleotides encoding male-gamete-disruptivepolynucleotides or polypeptides, cytotoxins, markers, or other malefertility sequences as disclosed elsewhere herein or known in the art.The stacked polynucleotides may be operably linked to the same promoteras the male-fertility polynucleotide, or may be operably linked to aseparate promoter polynucleotide.

As described elsewhere herein, expression cassettes may comprise apromoter operably linked to a polynucleotide of interest, along with acorresponding termination region. The termination region may be nativeto the transcriptional initiation region, may be native to the operablylinked male-fertility polynucleotide of interest or to themale-fertility promoter sequences, may be native to the plant host, ormay be derived from another source (i.e., foreign or heterologous).Convenient termination regions are available from the Ti-plasmid of A.tumefaciens, such as the octopine synthase and nopaline synthasetermination regions. See also Guerineau et al. (1991) Mol. Gen. Genet.262:141-144; Proudfoot (1991) Cell 64:671-674; Sanfacon et al. (1991)Genes Dev. 5:141-149; Mogen et al. (1990) Plant Cell 2:1261-1272; Munroeet al. (1990) Gene 91:151-158; Ballas et al. (1989) Nucleic Acids Res.17:7891-7903; and Joshi et al. (1987) Nucleic Acids Res. 15:9627-9639.

Where appropriate, the polynucleotides of interest may be optimized forincreased expression in the transformed plant. That is, thepolynucleotides can be synthesized or altered to use plant-preferredcodons for improved expression. See, for example, Campbell and Gown(1990) Plant Physiol. 92:1-11 for a discussion of host-preferred codonusage. Methods are available in the art for synthesizing plant-preferredgenes. See, for example, U.S. Pat. Nos. 5,380,831, and 5,436,391, andMurray et al. (1989) Nucleic Acids Res. 17:477-498, herein incorporatedby reference.

Additional sequence modifications are known to enhance gene expressionin a cellular host. These include elimination of sequences encodingspurious polyadenylation signals, exon-intron splice site signals,transposon-like repeats, and other such well-characterized sequencesthat may be deleterious to gene expression. The G-C content of thesequence may be adjusted to levels average for a given cellular host, ascalculated by reference to known genes expressed in the host cell. Whenpossible, the sequence is modified to avoid predicted hairpin secondarymRNA structures.

The expression cassettes may additionally contain 5′ leader sequences.Such leader sequences can act to enhance translation. Translationleaders are known in the art and include: picornavirus leaders, forexample, EMCV leader (Encephalomyocarditis 5′ noncoding region)(Elroy-Stein et al. (1989) Proc. Natl. Acad. Sci. USA 86:6126-6130);potyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Gallieet al. (1995) Gene 165(2):233-238), MDMV leader (Maize Dwarf MosaicVirus) (Johnson et al. (1986) Virology 154:9-20), and humanimmunoglobulin heavy-chain binding protein (BiP) (Macejak et al. (1991)Nature 353:90-94); untranslated leader from the coat protein mRNA ofalfalfa mosaic virus (AMV RNA 4) (Jobling et al. (1987) Nature325:622-625); tobacco mosaic virus leader (TMV) (Gallie et al. (1989) inMolecular Biology of RNA, ed. Cech (Liss, New York), pp. 237-256); andmaize chlorotic mottle virus leader (MCMV) (Lommel et al. (1991)Virology 81:382-385). See also, Della-Cioppa et al. (1987) PlantPhysiol. 84:965-968. Other methods known to enhance translation can alsobe utilized, for example, introns, and the like.

In preparing the expression cassette, the various DNA fragments may bemanipulated so as to provide for the DNA sequences in the properorientation and, as appropriate, in the proper reading frame. Towardthis end, adapters or linkers may be employed to join the DNA fragmentsor other manipulations may be involved to provide for convenientrestriction sites, removal of superfluous DNA, removal of restrictionsites, or the like. For this purpose, in vitro mutagenesis, primerrepair, restriction, annealing, resubstitutions, e.g., transitions andtransversions, may be involved.

In particular embodiments, the expression cassettes disclosed hereincomprise a promoter operably linked to a male-fertility polynucleotide,or fragment or variant thereof, as disclosed herein. In certainembodiments, a male-fertility promoter is operably linked to amale-fertility polynucleotide disclosed herein, such as themale-fertility polynucleotide set forth in SEQ ID NO: NOs: 32, 48, 64,66, or 68, or an active fragment or variant thereof.

Expression Vectors for Triticale Transformation: Marker Genes

Expression vectors include at least one genetic marker, operably linkedto a regulatory element (a promoter, for example) that allowstransformed cells containing the marker to be either recovered bynegative selection, i.e., inhibiting growth of cells that do not containthe selectable marker gene, or by positive selection, i.e., screeningfor the product encoded by the genetic marker. Many commonly usedselectable marker genes for plant transformation are well known in thetransformation arts, and include, for example, genes that code forenzymes that metabolically detoxify a selective chemical agent which maybe an antibiotic or an herbicide, or genes that encode an altered targetwhich is insensitive to the inhibitor. A few positive selection methodsare also known in the art.

One commonly used selectable marker gene for plant transformation is theneomycin phosphotransferase II (nptII), which, when under the control ofplant regulatory signals confers resistance to kanamycin. Fraley et al.,Proc. Natl. Acad. Sci. U.S.A., 80:4803 (1983). Another commonly usedselectable marker gene is the hygromycin phosphotransferase gene whichconfers resistance to the antibiotic hygromycin. Vanden Elzen et al.,Plant Mol. Biol., 5:299 (1985).

Additional selectable marker genes of bacterial origin that conferresistance to antibiotics include gentamycin acetyl transferase,streptomycin phosphotransferase, and aminoglycoside-3′-adenyltransferase, the bleomycin resistance determinant. Hayford et al., PlantPhysiol. 86:1216 (1988), Jones et al., Mol. Gen. Genet, 210:86 (1987),Svab et al., Plant Mol. Biol. 14:197 (1990) Hille et al., Plant Mol.Biol. 7:171 (1986). Other selectable marker genes confer resistance toherbicides such as glyphosate, glufosinate or bromoxynil. Comai et al.,Nature 317:741-744 (1985), Gordon-Kamm et al., Plant Cell 2:603-618(1990) and Stalker et al., Science 242:419-423 (1988).

Other selectable marker genes for plant transformation that are not ofbacterial origin include, for example, mouse dihydrofolate reductase,plant 5-enolpyruvyl-shikimate-3-phosphate synthase and plantacetolactate synthase. Eichholtz et al., Somatic Cell Mol. Genet. 13:67(1987), Shah et al., Science 233:478 (1986), Charest et al., Plant CellRep. 8:643 (1990).

Another class of marker genes for plant transformation requiresscreening of presumptively transformed plant cells rather than directgenetic selection of transformed cells for resistance to a toxicsubstance such as an antibiotic. These genes are particularly useful toquantify or visualize the spatial pattern of expression of a gene inspecific tissues and are frequently referred to as reporter genesbecause they can be fused to a gene or gene regulatory sequence for theinvestigation of gene expression. Commonly used genes for screeningpresumptively transformed cells include .beta.-glucuronidase (GUS),.beta.-galactosidase, luciferase and chloramphenicol acetyltransferase.Jefferson, R. A., Plant Mol. Biol. Rep. 5:387 (1987), Teeri et al., EMBOJ. 8:343 (1989), Koncz et al., Proc. Natl. Acad. Sci U.S.A. 84:131(1987), DeBlock et al., EMBO J. 3:1681 (1984).

In vivo methods for visualizing GUS activity that do not requiredestruction of plant tissue are available. Molecular Probes publication2908, Imagene Green, p. 1-4 (1993) and Naleway et al., J. Cell Biol.115:151a (1991). However, these in vivo methods for visualizing GUSactivity have not proven useful for recovery of transformed cellsbecause of low sensitivity, high fluorescent backgrounds and limitationsassociated with the use of luciferase genes as selectable markers.

The gene encoding Green Fluorescent Protein (GFP) has been utilized as amarker for gene expression in prokaryotic and eukaryotic cells. Chalfieet al., Science 263:802 (1994). GFP and mutants of GFP may be used asscreenable markers.

Expression Vectors for Triticale Transformation: Promoters

Genes included in expression vectors must be driven by a nucleotidesequence comprising a regulatory element, for example, a promoter.Several types of promoters are now well known in the transformationarts, as are other regulatory elements that can be used alone or incombination with promoters.

As used herein, “promoter” includes reference to a region of DNAupstream from the start of transcription and involved in recognition andbinding of RNA polymerase and other proteins to initiate transcription.A “plant promoter” is a promoter capable of initiating transcription inplant cells. Examples of promoters under developmental control includepromoters that preferentially initiate transcription in certain tissues,such as leaves, roots, seeds, fibers, xylem vessels, tracheids, orsclerenchyma. Such promoters are referred to as “tissue-preferred”.Promoters which initiate transcription only in certain tissue arereferred to as “tissue-specific”. A “cell type” specific promoterprimarily drives expression in certain cell types in one or more organs,for example, vascular cells in roots or leaves. An “inducible” promoteris a promoter which is under environmental control. Examples ofenvironmental conditions that may affect transcription by induciblepromoters include anaerobic conditions or the presence of light.Tissue-specific, tissue-preferred, cell type specific, and induciblepromoters constitute the class of “non-constitutive” promoters. A“constitutive” promoter is a promoter which is active under mostenvironmental conditions.

A constitutive promoter is operably linked to a gene for expression inwheat, or is operably linked to a nucleotide sequence encoding a signalsequence that is operably linked to a gene for expression in triticale.Many different constitutive promoters are available. Exemplaryconstitutive promoters include, but are not limited to, the promotersfrom plant viruses, such as the 35S promoter from CaMV and the promotersfrom such genes as rice actin; ubiquitin; pEMU; MAS, and maize H3histone. The ALS promoter, Xbal/Ncol fragment 5′ to the Brassica napusALS3 structural gene (or a nucleotide sequence similarity to saidXbal/Ncol fragment), represents a particularly useful constitutivepromoter.

A tissue-specific promoter or tissue-preferred promoter may be operablylinked to a gene for expression in triticale. Plants transformed with agene of interest operably linked to a tissue-specific promoter mayproduce the protein product of the transgene exclusively, orpreferentially, in a specific tissue. Any tissue-specific ortissue-preferred promoter can be utilized in the present invention.Exemplary tissue-specific or tissue-preferred promoters include, but arenot limited to, a root-preferred promoter, such as that from thephaseolin gene; a leaf-specific and light-induced promoter, such as thatfrom cab or rubisco; an anther-specific promoter, such as that fromLAT52; a pollen-specific promoter, such as that from Zml 3; or amicrospore-preferred promoter, such as that from apg.

An inducible regulatory element is one that is capable of directly orindirectly activating transcription of one or more DNA sequences orgenes in response to an inducer. In the absence of an inducer the DNAsequences or genes will not be transcribed. Any inducible promoter maybe used in the present invention. Exemplary inducible promoters include,but are not limited to, those from the ACEI system, which respond tocopper, and the In2 gene from maize, which responds tobenzene-sulfonamide herbicide safeners. In an embodiment, the induciblepromoter may be a promoter that responds to an inducing agent to whichplants do not normally respond. An exemplary inducible promoter may bean inducible promoter from a steroid hormone gene, the transcriptionalactivity of which is induced by a glucocorticosteroid hormone.

Signal Sequences for Targeting Proteins to Subcellular Compartments

Transport of protein produced by transgenes to a subcellular compartmentsuch as the chloroplast, vacuole, peroxisome, glyoxysome, cell wall ormitochondrion or for secretion into the apoplast, is accomplished bymeans of operably linking the nucleotide sequence encoding a signalsequence to the 5′ and/or 3′ region of a gene encoding the protein ofinterest. Targeting sequences at the 5′ and/or 3′ end of the structuralgene may determine, during protein synthesis and processing, where theencoded protein is ultimately compartmentalized.

The presence of a signal sequence directs a polypeptide to either anintracellular organelle or subcellular compartment or for secretion tothe apoplast. Many signal sequences are known in the art. See, forexample Becker et al., Plant Mol. Biol. 20:49 (1992); Close, P. S.,Master's Thesis, Iowa State University (1993); Knox, C., et al., PlantMol. Biol. 9:3-17 (1987); Lerner et al., Plant Physiol. 91:124-129(1989); Fontes et al., Plant Cell 3:483-496 (1991); Matsuoka et al.,Proc. Natl. Acad. Sci. 88:834 (1991); Gould et al., J. Cell. Biol.108:1657 (1989); Creissen et al., Plant J. 2:129 (1991); Kalderon, etal., Cell 39:499-509 (1984); Steifel, et al., Plant Cell 2:785-793(1990).

Heterologous Protein Genes and Agronomic Genes

With transgenic plants, a heterologous protein can be produced incommercial quantities. Thus, techniques for the selection andpropagation of transformed plants, which are well understood in the art,yield a plurality of transgenic plants which are harvested in aconventional manner, and a foreign protein then can be extracted from atissue of interest or from total biomass. Protein extraction from plantbiomass can be accomplished by known methods which are discussed, forexample, by Heney and Orr, Anal. Biochem. 114:92-6 (1981). According toan embodiment, the transgenic plant provided for commercial productionof foreign protein is a triticale plant. In another preferredembodiment, the biomass of interest is seed. For the relatively smallnumber of transgenic plants that show higher levels of expression, agenetic map can be generated, primarily via conventional RFLP, PCR andSSR analysis, which identifies the approximate chromosomal location ofthe integrated DNA molecule. For exemplary methodologies in this regard,see Glick and Thompson, Methods in Plant Molecular Biology andBiotechnology CRC Press, Boca Raton 269:284 (1993). Map informationconcerning chromosomal location is useful for proprietary protection ofa subject transgenic plant. If unauthorized propagation is undertakenand crosses made with other germplasm, the map of the integration regioncan be compared to similar maps for suspect plants, to determine if thelatter have a common parentage with the subject plant. Map comparisonswould involve hybridizations, RFLP, PCR, SSR and sequencing, all ofwhich are conventional techniques.

Likewise, by means of the present invention, agronomic genes can beexpressed in transformed plants. More particularly, plants can begenetically engineered to express various phenotypes of agronomicinterest. Exemplary genes implicated in this regard include, but are notlimited to, those categorized below:

1. Genes that Confer Resistance to Pests or Disease and that Encode:

A. Plant disease resistance genes. Plant defenses are often activated byspecific interaction between the product of a disease resistance gene(R) in the plant and the product of a corresponding avirulence (Avr)gene in the pathogen. A plant variety can be transformed with clonedresistance gene to engineer plants that are resistant to specificpathogen strains. See, for example Jones et al., Science 266:789 (1994)(cloning of the tomato Cf-9 gene for resistance to Cladosporium fulvum);Martin et al., Science 262:1432 (1993) (tomato Pto gene for resistanceto Pseudomonas syringae pv. tomato encodes a protein kinase); Mindrinoset al., Cell 78:1089 (1994) (Arabidopsis RSP2 gene for resistance toPseudomonas syringae).B. A gene conferring resistance to a pest, such as nematodes. See e.g.,PCT Application WO 96/30517; PCT Application WO 93/19181.C. A Bacillus thuringiensis protein, a derivative thereof or a syntheticpolypeptide modeled thereon. See, for example, Geiser et al., Gene48:109 (1986), who disclose the cloning and nucleotide sequence of a Btδ-endotoxin gene. Moreover, DNA molecules encoding .delta.-endotoxingenes can be purchased from American Type Culture Collection, Manassas,Va., for example, under ATCC Accession Nos. 40098, 67136, 31995 and31998.D. A lectin. See, for example, the disclosure by Van Damme et al., PlantMolec. Biol. 24:25 (1994), who disclose the nucleotide sequences ofseveral Clivia miniata mannose-binding lectin genes.E. A vitamin-binding protein such as avidin. See PCT applicationUS93/06487. The application teaches the use of avidin and avidinhomologues as larvicides against insect pests.F. An enzyme inhibitor, for example, a protease or proteinase inhibitoror an amylase inhibitor. See, for example, Abe et al., J. Biol. Chem.262:16793 (1987) (nucleotide sequence of rice cysteine proteinaseinhibitor), Huub et al., Plant Molec. Biol. 21:985 (1993) (nucleotidesequence of cDNA encoding tobacco proteinase inhibitor I), Sumitani etal., Biosci. Biotech. Biochem. 57:1243 (1993) (nucleotide sequence ofStreptomyces nitrosporeus α-amylase inhibitor) and U.S. Pat. No.5,494,813 (Hepher and Atkinson, issued Feb. 27, 1996).G. An insect-specific hormone or pheromone such as an ecdysteroid andjuvenile hormone, a variant thereof, a mimetic based thereon, or anantagonist or agonist thereof. See, for example, the disclosure byHammock et al., Nature 344:458 (1990), of baculovirus expression ofcloned juvenile hormone esterase, an inactivator of juvenile hormone.H. An insect-specific peptide or neuropeptide which, upon expression,disrupts the physiology of the affected pest. For example, see thedisclosures of Regan, J. Biol. Chem. 269:9 (1994) (expression cloningyields DNA coding for insect diuretic hormone receptor), and Pratt etal., Biochem. Biophys. Res. Comm. 163:1243 (1989) (an allostatin isidentified in Diploptera puntata). See also U.S. Pat. No. 5,266,317 toTomalski et al., who disclose genes encoding insect-specific, paralyticneurotoxins.I. An insect-specific venom produced in nature by a snake, a wasp, etc.For example, see Pang et al., Gene 116:165 (1992), for disclosure ofheterologous expression in plants of a gene coding for a scorpioninsectotoxic peptide.J. An enzyme responsible for a hyper-accumulation of a monoterpene, asesquiterpene, a steroid, a hydroxamic acid, a phenylpropanoidderivative or another non-protein molecule with insecticidal activity.K. An enzyme involved in the modification, including thepost-translational modification, of a biologically active molecule; forexample, a glycolytic enzyme, a proteolytic enzyme, a lipolytic enzyme,a nuclease, a cyclase, a transaminase, an esterase, a hydrolase, aphosphatase, a kinase, a phosphorylase, a polymerase, an elastase, achitinase and a glucanase, whether natural or synthetic. See PCTapplication WO 93/02197 in the name of Scott et al., which discloses thenucleotide sequence of a callase gene. DNA molecules which containchitinase-encoding sequences can be obtained, for example, from the ATCCunder Accession Nos. 39637 and 67152. See also Kramer et al., InsectBiochem. Molec. Biol. 23:691 (1993), who teach the nucleotide sequenceof a cDNA encoding tobacco hookworm chitinase, and Kawalleck et al.,Plant Molec. Biol. 21:673 (1993), who provide the nucleotide sequence ofthe parsley ubi4-2 polyubiquitin gene.L. A molecule that stimulates signal transduction. For example, see thedisclosure by Botella et al., Plant Molec. Biol. 24:757 (1994), ofnucleotide sequences for mung bean calmodulin cDNA clones, and Griess etal., Plant Physiol. 104:1467 (1994), who provide the nucleotide sequenceof a maize calmodulin cDNA clone.M. A hydrophobic moment peptide. See PCT application WO 95/16776(disclosure of peptide derivatives of Tachyplesin which inhibit fungalplant pathogens) and PCT application WO 95/18855 (teaches syntheticantimicrobial peptides that confer disease resistance).N. A membrane permease, a channel former or a channel blocker. Forexample, see the disclosure of Jaynes et al., Plant Sci 89:43 (1993), ofheterologous expression of a cecropin-.beta. lytic peptide analog torender transgenic tobacco plants resistant to Pseudomonas solanacearum.O. A viral-invasive protein or a complex toxin derived therefrom. Forexample, the accumulation of viral coat proteins in transformed plantcells imparts resistance to viral infection and/or disease developmenteffected by the virus from which the coat protein gene is derived, aswell as by related viruses. See Beachy et al., Ann. Rev. Phytopathol.28:451 (1990). Coat protein-mediated resistance has been conferred upontransformed plants against alfalfa mosaic virus, cucumber mosaic virus,tobacco streak virus, potato virus X, potato virus Y, tobacco etchvirus, tobacco rattle virus and tobacco mosaic virus. Id.P. An insect-specific antibody or an immunotoxin derived therefrom.Thus, an antibody targeted to a critical metabolic function in theinsect gut would inactivate an affected enzyme, killing the insect. Cf.Taylor et al., Abstract #497, Seventh Int'l Symposium on MolecularPlant-Microbe Interactions (Edinburgh, Scotland) (1994) (enzymaticinactivation in transgenic tobacco via production of single-chainantibody fragments).Q. A virus-specific antibody. See, for example, Taviadoraki et al.,Nature 366:469 (1993), who show that transgenic plants expressingrecombinant antibody genes are protected from virus attack.R. A developmental-arrestive protein produced in nature by a pathogen ora parasite. Thus, fungal endo-.alpha.-1,4-D-polygalacturonasesfacilitate fungal colonization and plant nutrient release bysolubilizing plant cell wall homo-.alpha.-1,4-D-galacturonase. See Lambet al., Bio/Technology 10:1436 (1992). The cloning and characterizationof a gene which encodes a bean endopolygalacturonase-inhibiting proteinis described by Toubart et al., Plant J. 2:367 (1992).S. A developmental-arrestive protein produced in nature by a plant. Forexample, Logemann et al., Bio/Technology 10:305 (1992), have shown thattransgenic plants expressing the barley ribosome-inactivating gene havean increased resistance to fungal disease.2. Genes that Confer Resistance to an Herbicide:A. An herbicide that inhibits the growing point or meristem, such as animidazolinone or a sulfonylurea. Exemplary genes in this category codefor mutant ALS and AHAS enzyme as described, for example, by Lee et al.,EMBO J. 7:1241 (1988), and Miki et al., Theor. Appl. Genet. 80:449(1990), respectively.B. Glyphosate (resistance conferred by mutant5-enolpyruvlshikimate-3-phosphate synthase (EPSP) and aroA genes,respectively) and other phosphono compounds such as glufosinate(phosphinothricin acetyl transferase (PAT) and Streptomyceshygroscopicus PAT, bar, genes), and pyridinoxy or phenoxy proprionicacids and cyclohexones (ACCase inhibitor-encoding genes). See, forexample, U.S. Pat. No. 4,940,835 to Shah, et al., which discloses thenucleotide sequence of a form of EPSP which can confer glyphosateresistance. A DNA molecule encoding a mutant aroA gene can be obtainedunder ATCC accession number 39256, and the nucleotide sequence of themutant gene is disclosed in U.S. Pat. No. 4,769,061 to Comai. Europeanpatent application No. 0 333 033 to Kumada et al., and U.S. Pat. No.4,975,374 to Goodman et al., disclose nucleotide sequences of glutaminesynthetase genes which confer resistance to herbicides such asL-phosphinothricin. The nucleotide sequence of a PAT gene is provided inEuropean application No. 0 242 246 to Leemans et al. DeGreef et al.,Bio/Technology 7:61 (1989), describe the production of transgenic plantsthat express chimeric bar genes coding for PAT activity. Exemplary ofgenes conferring resistance to phenoxy proprionic acids andcyclohexones, such as sethoxydim and haloxyfop are the Acc1-S1, Acc1-S2and Acc1-S3 genes described by Marshall et al., Theor. Appl. Genet.83:435 (1992).C. An herbicide that inhibits photosynthesis, such as a triazine (psbAand gs+ genes) or a benzonitrile (nitrilase gene). Przibila et al.,Plant Cell 3:169 (1991), describe the transformation of Chlamydomonaswith plasmids encoding mutant psbA genes. Nucleotide sequences fornitrilase genes are disclosed in U.S. Pat. No. 4,810,648 to Stalker, andDNA molecules containing these genes are available under ATCC AccessionNos. 53435, 67441, and 67442. Cloning and expression of DNA coding for aglutathione S-transferase is described by Hayes et al., Biochem. J.285:173 (1992).D. Acetohydroxy acid synthase, which has been found to make plants thatexpress this enzyme resistant to multiple types of herbicides, has beenintroduced into a variety of plants. See Hattori et al., Mol. Gen.Genet. 246:419, 1995. Other genes that confer tolerance to herbicidesinclude a gene encoding a chimeric protein of rat cytochrome P4507A1 andyeast NADPH-cytochrome P450 oxidoreductase (Shiota et al., PlantPhysiol., 106:17, 1994), genes for glutathione reductase and superoxidedismutase (Aono et al., Plant Cell Physiol. 36:1687, 1995), and genesfor various phosphotransferases (Datta et al., Plant Mol. Biol. 20:619,1992).E. Protoporphyrinogen oxidase (protox) is necessary for the productionof chlorophyll, which is necessary for all plant survival. The protoxenzyme serves as the target for a variety of herbicidal compounds. Theseherbicides also inhibit growth of all the different species of plantspresent, causing their total destruction. The development of plantscontaining altered protox activity which are resistant to theseherbicides are described in U.S. Pat. Nos. 6,288,306; 6,282,837;5,767,373; and international publication WO 01/12825.3. Genes that Confer or Contribute to a Value-Added Trait, Such as:A. Modified fatty acid metabolism, for example, by transforming a plantwith an antisense gene of stearyl-ACP desaturase to increase stearicacid content of the plant. See Knultzon et al., Proc. Nat. Acad. Sci.U.S.A. 89:2624 (1992).B. Decreased phytate content—1) Introduction of a phytase-encoding genewould enhance breakdown of phytate, adding more free phosphate to thetransformed plant. For example, see Van Hartingsveldt et al., Gene127:87 (1993), for a disclosure of the nucleotide sequence of anAspergillus niger phytase gene. 2) A gene could be introduced thatreduced phytate content. In maize, this, for example, could beaccomplished, by cloning and then reintroducing DNA associated with thesingle allele which is responsible for maize mutants characterized bylow levels of phytic acid. See Raboy et al., Maydica 35:383 (1990).C. Modified carbohydrate composition effected, for example, bytransforming plants with a gene coding for an enzyme that alters thebranching pattern of starch. See Shiroza et al., J. Bacteol. 170:810(1988) (nucleotide sequence of Streptococcus mutantsfructosyltransferase gene), Steinmetz et al., Mol. Gen. Genet. 20:220(1985) (nucleotide sequence of Bacillus subtilis levansucrase gene), Penet al., Bio/Technology 10:292 (1992) (production of transgenic plantsthat express Bacillus licheniformis .alpha.-amylase), Elliot et al.,Plant Molec. Biol. 21:515 (1993) (nucleotide sequences of tomatoinvertase genes), SOgaard et al., J. Biol. Chem. 268:22480 (1993)(site-directed mutagenesis of barley .alpha.-amylase gene), and Fisheret al., Plant Physiol. 102:1045 (1993) (maize endosperm starch branchingenzyme II).D. Elevated oleic acid via FAD-2 gene modification and/or decreasedlinolenic acid via FAD-3 gene modification. See U.S. Pat. Nos.6,063,947; 6,323,392; and international publication WO 93/11245.E. The content of high-molecular weight gluten subunits (HMS-GS).Genomic clones have been isolated for different subunits (Anderson etal., In Proceedings of the 7.sup.th International Wheat GeneticsSymposium, IPR, pp. 699-704, 1988; Shewry et al. In Oxford Surveys ofPlant Molecular and Cell Biology, pp. 163-219, 1989; Shewry et al.Journal of Cereal Sci. 15:105-120, 1992). Blechl et al. (Journal ofPlant Phys. 152 (6): 703-707, 1998) have transformed wheat with genesthat encode a modified HMW-GS. See also U.S. Pat. Nos. 5,650,558;5,914,450; 5,985,352; 6,174,725; and 6,252,134, which are incorporatedherein by reference for this purpose.4. Genes that Control Male SterilityA. Introduction of a deacetylase gene under the control of atapetum-specific promoter and with the application of the chemicalN-Ac-PPT. See international publication WO 01/29237.B. Introduction of various stamen-specific promoters. See internationalpublications WO 92/13956 and WO 92/13957.C. Introduction of the barnase and the barstar genes. See Paul et al.,Plant Mol. Biol. 19:611-622, 1992).Methods for Triticale Transformation

The methods disclosed herein comprise introducing a polypeptide orpolynucleotide into a plant cell. “Introducing” is intended to meanpresenting to the plant the polynucleotide or polypeptide in such amanner that the sequence gains access to the interior of a cell. Themethods disclosed herein do not depend on a particular method forintroducing a sequence into the host cell, only that the polynucleotideor polypeptides gains access to the interior of at least one cell of thehost. Methods for introducing polynucleotide or polypeptides into hostcells (i.e., plants) are known in the art and include, but are notlimited to, stable transformation methods, transient transformationmethods, and virus-mediated methods.

“Stable transformation” is intended to mean that the nucleotideconstruct introduced into a host (i.e., a plant) integrates into thegenome of the plant and is capable of being inherited by the progenythereof. “Transient transformation” is intended to mean that apolynucleotide or polypeptide is introduced into the host (i.e., aplant) and expressed temporally.

Numerous methods for plant transformation have been developed, includingbiological and physical, plant transformation protocols. See, forexample, Miki et al., “Procedures for Introducing Foreign DNA intoPlants” in Methods in Plant Molecular Biology and Biotechnology, GlickB. R. and Thompson, J. E. Eds. (CRC Press, Inc., Boca Raton, 1993) pages67-88. In addition, expression vectors and in vitro culture methods forplant cell or tissue transformation and regeneration of plants areavailable. See, for example, Gruber et al., “Vectors for PlantTransformation” in Methods in Plant Molecular Biology and Biotechnology,Glick B. R. and Thompson, J. E. Eds. (CRC Press, Inc., Boca Raton, 1993)pages 89-119.

A. Agrobacterium-mediated Transformation—One method for introducing anexpression vector into plants is based on the natural transformationsystem of Agrobacterium. See, for example, Horsch et al., Science227:1229 (1985). A. tumefaciens and A. rhizogenes are plant pathogenicsoil bacteria which genetically transform plant cells. The Ti and Riplasmids of A. tumefaciens and A. rhizogenes, respectively, carry genesresponsible for genetic transformation of the plant. See, for example,Kado, C. I., Crit. Rev. Plant Sci. 10:1 (1991). Descriptions ofAgrobacterium vector systems and methods for Agrobacterium-mediated genetransfer are provided by Gruber et al., supra, Miki et al., supra, andMoloney et al., Plant Cell Reports 8:238 (1989). See also, U.S. Pat. No.5,563,055 (Townsend and Thomas), issued Oct. 8, 1996.B. Direct Gene Transfer—Several methods of plant transformation,collectively referred to as direct gene transfer, have been developed asan alternative to Agrobacterium-mediated transformation. A generallyapplicable method of plant transformation is microprojectile-mediatedtransformation wherein DNA is carried on the surface ofmicroprojectiles. The expression vector is introduced into plant tissueswith a biolistic device that accelerates the microprojectiles to speedsof 300 to 600 m/s which is sufficient to penetrate plant cell walls andmembranes. Sanford et al., Part. Sci. Technol. 5:27 (1987), Sanford, J.C., Trends Biotech. 6:299 (1988), Klein et al., Bio/Technology 6:559-563(1988), Sanford, J. C., Physiol Plant 7:206 (1990), Klein et al.,Biotechnology 10:268 (1992). See also U.S. Pat. No. 5,015,580 (Christou,et al.), issued May 14, 1991; U.S. Pat. No. 5,322,783 (Tomes, et al.),issued Jun. 21, 1994.

Another method for physical delivery of DNA to plants is sonication oftarget cells. Zhang et al., Bio/Technology 9:996 (1991). Alternatively,liposome and spheroplast fusion have been used to introduce expressionvectors into plants. Deshayes et al., EMBO J, 4:2731 (1985), Christou etal., Proc Natl. Acad. Sci. U.S.A. 84:3962 (1987). Direct uptake of DNAinto protoplasts using CaCl₂ precipitation, polyvinyl alcohol orpoly-L-omithine has also been reported. Hain et al., Mol. Gen. Genet.199:161 (1985) and Draper et al., Plant Cell Physiol. 23:451 (1982).Electroporation of protoplasts and whole cells and tissues has also beendescribed. Donn et al., In Abstracts of VIIth International Congress onPlant Cell and Tissue Culture IAPTC, A2-38, p 53 (1990); D'Halluin etal., Plant Cell 4:1495-1505 (1992) and Spencer et al., Plant Mol. Biol.24:51-61 (1994).

Following transformation of triticale target tissues, expression of theabove-described selectable marker genes allows for preferentialselection of transformed cells, tissues and/or plants, usingregeneration and selection methods now well known in the art.

In specific embodiments, the male-fertility polynucleotides orexpression cassettes disclosed herein can be provided to a plant using avariety of transient transformation methods. Such transienttransformation methods include, but are not limited to, the introductionof the male-fertility polypeptide or variants and fragments thereofdirectly into the plant or the introduction of a male fertilitytranscript into the plant. Such methods include, for example,microinjection or particle bombardment. See, for example, Crossway etal. (1986) Mol Gen. Genet. 202:179-185; Nomura et al. (1986) Plant Sci.44:53-58; Hepler et al. (1994) Proc. Natl. Acad. Sci. 91: 2176-2180 andHush et al. (1994) The Journal of Cell Science 107:775-784, all of whichare herein incorporated by reference. Alternatively, the male-fertilitypolynucleotide or expression cassettes disclosed herein can betransiently transformed into the plant using techniques known in theart. Such techniques include viral vector system and the precipitationof the polynucleotide in a manner that precludes subsequent release ofthe DNA. Thus, the transcription from the particle-bound DNA can occur,but the frequency with which it is released to become integrated intothe genome is greatly reduced. Such methods include the use of particlescoated with polyethylimine (PEI; Sigma #P3143).

In other embodiments, the male-fertility polynucleotides or expressioncassettes disclosed herein may be introduced into plants by contactingplants with a virus or viral nucleic acids. Generally, such methodsinvolve incorporating a nucleotide construct disclosed herein within aviral DNA or RNA molecule. It is recognized that a male fertilitysequence disclosed herein may be initially synthesized as part of aviral polyprotein, which later may be processed by proteolysis in vivoor in vitro to produce the desired recombinant protein. Methods forintroducing polynucleotides into plants and expressing a protein encodedtherein, involving viral DNA or RNA molecules, are known in the art.See, for example, U.S. Pat. Nos. 5,889,191, 5,889,190, 5,866,785,5,589,367, 5,316,931, and Porta et al. (1996) Molecular Biotechnology5:209-221; herein incorporated by reference.

Methods are known in the art for the targeted insertion of apolynucleotide at a specific location in the plant genome. In oneembodiment, the insertion of the polynucleotide at a desired genomiclocation is achieved using a site-specific recombination system. See,for example, WO99/25821, WO99/25854, WO99/25840, WO99/25855, andWO99/25853, all of which are herein incorporated by reference. Briefly,a polynucleotide disclosed herein can be contained in a transfercassette flanked by two non-identical recombination sites. The transfercassette is introduced into a plant having stably incorporated into itsgenome a target site which is flanked by two non-identical recombinationsites that correspond to the sites of the transfer cassette. Anappropriate recombinase is provided and the transfer cassette isintegrated at the target site. The polynucleotide of interest is therebyintegrated at a specific chromosomal position in the plant genome.

The cells that have been transformed may be grown into plants inaccordance with conventional ways. See, for example, McCormick et al.(1986) Plant Cell Reports 5:81-84. These plants may then be pollinatedwith either the same transformed strain or a different strain, and theresulting progeny having desired expression of the desired phenotypiccharacteristic identified. Two or more generations may be grown toensure that expression of the desired phenotypic characteristic isstably maintained and inherited and then seeds harvested to ensureexpression of the desired phenotypic characteristic has been achieved.In this manner, the present disclosure provides transformed seed (alsoreferred to as “transgenic seed”) having a male-fertility polynucleotidedisclosed herein, for example, an expression cassette disclosed herein,stably incorporated into their genome.

The foregoing methods for transformation would typically be used forproducing a transgenic variety. The transgenic variety could then becrossed, with another (non-transformed or transformed) variety, in orderto produce a new transgenic variety. Alternatively, a genetic traitwhich has been engineered into a particular triticale cultivar using theforegoing transformation techniques could be moved into another cultivarusing traditional backcrossing techniques that are well known in theplant breeding arts. For example, a backcrossing approach could be usedto move an engineered trait from a public, non-elite variety into anelite variety, or from a variety containing a foreign gene in its genomeinto a variety or varieties which do not contain that gene. As usedherein, “crossing” can refer to a simple X by Y cross, or the process ofbackcrossing, depending on the context.

Genome Editing

The terms “target site”, “target sequence”, “target DNA”, “targetlocus”, “genomic target site”, “genomic target sequence”, and “genomictarget locus” are used interchangeably herein and refer to apolynucleotide sequence in the genome (including chloroplast andmitochondrial DNA) of a cell at which a double-strand break is inducedin the cell genome. The target site can be an endogenous site in thegenome of a cell or organism, or alternatively, the target site can beheterologous to the cell or organism and thereby not be naturallyoccurring in the genome, or the target site can be found in aheterologous genomic location compared to where it occurs in nature. Asused herein, terms “endogenous target sequence” and “native targetsequence” are used interchangeably herein to refer to a target sequencethat is endogenous or native to the genome of a cell or organism and isat the endogenous or native position of that target sequence in thegenome of a cell or organism. Cells include plant cells as well asplants and seeds produced by the methods described herein.

In one embodiments, the target site, in association with the particulargene editing system that is being used, can be similar to a DNArecognition site or target site that is specifically recognized and/orbound by a double-strand-break-inducing agent, such as but not limitedto a Zinc Finger endonuclease, a meganuclease, a TALEN endonuclease, aCRISPR-Cas guideRNA or other polynucleotide guided double strand breakreagent.

The terms “artificial target site” and “artificial target sequence” areused interchangeably herein and refer to a target sequence that has beenintroduced into the genome of a cell or organism. Such an artificialtarget sequence can be identical in sequence to an endogenous or nativetarget sequence in the genome of a cell but be located in a differentposition (i.e., a non-endogenous or non-native position) in the genomeof a cell or organism.

The terms “altered target site”, “altered target sequence”, “modifiedtarget site”, and “modified target sequence” are used interchangeablyherein and refer to a target sequence as disclosed herein that comprisesat least one alteration when compared to non-altered target sequence.Such “alterations” include, for example: (i) replacement of at least onenucleotide, (ii) a deletion of at least one nucleotide, (iii) aninsertion of at least one nucleotide, or (iv) any combination of(i)-(iii).

Certain embodiments comprise polynucleotides disclosed herein which aremodified using endonucleases. Endonucleases are enzymes that cleave thephosphodiester bond within a polynucleotide chain, and includerestriction endonucleases that cleave DNA at specific sites withoutdamaging the bases. Restriction endonucleases include Type I, Type II,Type III, and Type IV endonucleases, which further include subtypes. Inthe Type I and Type III systems, both the methylase and restrictionactivities are contained in a single complex.

Endonucleases also include meganucleases, also known as homingendonucleases (HEases). Like restriction endonucleases, HEases bind andcut at a specific recognition site. However, the recognition sites formeganucleases are typically longer, about 18 bp or more. (See patentpublication WO2012/129373 filed on Mar. 22, 2012). Meganucleases havebeen classified into four families based on conserved sequence motifs(Belfort M, and Perlman P S J. Biol. Chem. 1995; 270:30237-30240). Thesemotifs participate in the coordination of metal ions and hydrolysis ofphosphodiester bonds. HEases are notable for their long recognitionsites, and for tolerating some sequence polymorphisms in their DNAsubstrates.

The naming convention for meganucleases is similar to the convention forother restriction endonuclease. Meganucleases are also characterized byprefix F-, I-, or PI- for enzymes encoded by free-standing ORFs,introns, and inteins, respectively. One step in the recombinationprocess involves polynucleotide cleavage at or near the recognitionsite. This cleaving activity can be used to produce a double-strandbreak. For reviews of site-specific recombinases and their recognitionsites, see, Sauer (1994) Curr. Op. Biotechnol. 5:521-7; and Sadowski(1993) FASEB 7:760-7. In some examples the recombinase is from theIntegrase or Resolvase families.

TAL effector nucleases are a class of sequence-specific nucleases thatcan be used to make double-strand breaks at specific target sequences inthe genome of a plant or other organism. (Miller et al. (2011) NatureBiotechnology 29:143-148). Zinc finger nucleases (ZFNs) are engineereddouble-strand-break-inducing agents comprised of a zinc finger DNAbinding domain and a double-strand-break-inducing agent domain.Recognition site specificity is conferred by the zinc finger domain,which typically comprises two, three, or four zinc fingers, for examplehaving a C2H2 structure; however other zinc finger structures are knownand have been engineered. Zinc finger domains are amenable for designingpolypeptides which specifically bind a selected polynucleotiderecognition sequence. ZFNs include engineered DNA-binding zinc fingerdomain linked to a non-specific endonuclease domain, for examplenuclease domain from a Type IIs endonuclease such as FokI. Additionalfunctionalities can be fused to the zinc-finger binding domain,including transcriptional activator domains, transcription repressordomains, and methylases. In some examples, dimerization of nucleasedomain is required for cleavage activity. Each zinc finger recognizesthree consecutive base pairs in the target DNA. For example, a 3-fingerdomain recognizes a sequence of 9 contiguous nucleotides; with adimerization requirement of the nuclease, two sets of zinc fingertriplets are used to bind an 18-nucleotide recognition sequence.

CRISPR loci (Clustered Regularly Interspaced Short Palindromic Repeats)(also known as SPIDRs—SPacer Interspersed Direct Repeats) constitute afamily of recently described DNA loci. CRISPR loci consist of short andhighly conserved DNA repeats (typically 24 to 40 bp, repeated from 1 to140 times—also referred to as CRISPR-repeats) which are partiallypalindromic. The repeated sequences (usually specific to a species) areinterspaced by variable sequences of constant length (typically 20 to 58by depending on the CRISPR locus (WO2007/025097 published Mar. 1, 2007).

CRISPR loci were first recognized in E. coli (Ishino et al. (1987) J.Bacterial. 169:5429-5433; Nakata et al. (1989) J. Bacterial.171:3553-3556). Similar interspersed short sequence repeats have beenidentified in Haloferax mediterranei, Streptococcus pyogenes, Anabaena,and Mycobacterium tuberculosis (Groenen et al. (1993) Mol. Microbiol.10:1057-1065; Hoe et al. (1999) Emerg. Infect. Dis. 5:254-263; Masepohlet al. (1996) Biochim. Biophys. Acta 1307:26-30; Mojica et al. (1995)Mol. Microbiol. 17:85-93). The CRISPR loci differ from other SSRs by thestructure of the repeats, which have been termed short regularly spacedrepeats (SRSRs) (Janssen et al. (2002) OMICS J. Integ. Biol. 6:23-33;Mojica et al. (2000) Mol. Microbiol. 36:244-246). The repeats are shortelements that occur in clusters, that are always regularly spaced byvariable sequences of constant length (Mojica et al. (2000) Mol.Microbiol. 36:244-246).

Cas gene relates to a gene that is generally coupled, associated orclose to or in the vicinity of flanking CRISPR loci. The terms “Casgene”, “CRISPR-associated (Cas) gene” are used interchangeably herein. Acomprehensive review of the Cas protein family is presented in Haft etal. (2005) Computational Biology, PLoS Comput Biol 1(6): e60.doi:10.1371/journal.pcbi.0010060. As described therein, 41CRISPR-associated (Cas) gene families are described, in addition to thefour previously known gene families. It shows that CRISPR systems belongto different classes, with different repeat patterns, sets of genes, andspecies ranges. The number of Cas genes at a given CRISPR locus can varybetween species.

Cas endonuclease relates to a Cas protein encoded by a Cas gene, whereinsaid Cas protein is capable of introducing a double strand break into aDNA target sequence. The Cas endonuclease is guided by a guidepolynucleotide to recognize and optionally introduce a double strandbreak at a specific target site into the genome of a cell (U.S.Provisional Application No. 62/023,239, filed Jul. 11, 2014). The guidepolynucleotide/Cas endonuclease system includes a complex of a Casendonuclease and a guide polynucleotide that is capable of introducing adouble strand break into a DNA target sequence. The Cas endonucleaseunwinds the DNA duplex in close proximity of the genomic target site andcleaves both DNA strands upon recognition of a target sequence by aguide RNA if a correct protospacer-adjacent motif (PAM) is approximatelyoriented at the 3′ end of the target sequence.

The Cas endonuclease gene can be Cas9 endonuclease, or a functionalfragment thereof, such as but not limited to, Cas9 genes listed in SEQID NOs: 462, 474, 489, 494, 499, 505, and 518 of WO2007/025097 publishedMar. 1, 2007. The Cas endonuclease gene can be a plant, maize or soybeanoptimized Cas9 endonuclease, such as but not limited to a plant codonoptimized Streptococcus pyogenes Cas9 gene that can recognize anygenomic sequence of the form N(12-30)NGG. The Cas endonuclease can beintroduced directly into a cell by any method known in the art, forexample, but not limited to transient introduction methods, transfectionand/or topical application.

As used herein, the term “guide RNA” relates to a synthetic fusion oftwo RNA molecules, a crRNA (CRISPR RNA) comprising a variable targetingdomain, and a tracrRNA. In one embodiment, the guide RNA comprises avariable targeting domain of 12 to 30 nucleotide sequences and a RNAfragment that can interact with a Cas endonuclease.

As used herein, the term “guide polynucleotide”, relates to apolynucleotide sequence that can form a complex with a Cas endonucleaseand enables the Cas endonuclease to recognize and optionally cleave aDNA target site (U.S. Provisional Application No. 62/023,239, filed Jul.11, 2014). The guide polynucleotide can be a single molecule or a doublemolecule. The guide polynucleotide sequence can be a RNA sequence, a DNAsequence, or a combination thereof (a RNA-DNA combination sequence).Optionally, the guide polynucleotide can comprise at least onenucleotide, phosphodiester bond or linkage modification such as, but notlimited, to Locked Nucleic Acid (LNA), 5-methyl dC, 2,6-Diaminopurine,2′-Fluoro A, 2′-Fluoro U, 2′-O-Methyl RNA, phosphorothioate bond,linkage to a cholesterol molecule, linkage to a polyethylene glycolmolecule, linkage to a spacer 18 (hexaethylene glycol chain) molecule,or 5′ to 3′ covalent linkage resulting in circularization. A guidepolynucleotide that solely comprises ribonucleic acids is also referredto as a “guide RNA”.

The guide polynucleotide can be a double molecule (also referred to asduplex guide polynucleotide) comprising a first nucleotide sequencedomain (referred to as Variable Targeting domain or VT domain) that iscomplementary to a nucleotide sequence in a target DNA and a secondnucleotide sequence domain (referred to as Cas endonuclease recognitiondomain or CER domain) that interacts with a Cas endonucleasepolypeptide. The CER domain of the double molecule guide polynucleotidecomprises two separate molecules that are hybridized along a region ofcomplementarity. The two separate molecules can be RNA, DNA, and/orRNA-DNA-combination sequences. In some embodiments, the first moleculeof the duplex guide polynucleotide comprising a VT domain linked to aCER domain is referred to as “crDNA” (when composed of a contiguousstretch of DNA nucleotides) or “crRNA” (when composed of a contiguousstretch of RNA nucleotides), or “crDNA-RNA” (when composed of acombination of DNA and RNA nucleotides). The crNucleotide can comprise afragment of the cRNA naturally occurring in Bacteria and Archaea. In oneembodiment, the size of the fragment of the cRNA naturally occurring inBacteria and Archaea that is present in a crNucleotide disclosed hereincan range from, but is not limited to, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,12, 13, 14, 15, 16, 17, 18, 19, 20 or more nucleotides. In someembodiments the second molecule of the duplex guide polynucleotidecomprising a CER domain is referred to as “tracrRNA” (when composed of acontiguous stretch of RNA nucleotides) or “tracrDNA” (when composed of acontiguous stretch of DNA nucleotides) or “tracrDNA-RNA” (when composedof a combination of DNA and RNA nucleotides. In one embodiment, the RNAthat guides the RNA/Cas9 endonuclease complex, is a duplexed RNAcomprising a duplex crRNA-tracrRNA.

The guide polynucleotide can also be a single molecule comprising afirst nucleotide sequence domain (referred to as Variable Targetingdomain or VT domain) that is complementary to a nucleotide sequence in atarget DNA and a second nucleotide domain (referred to as Casendonuclease recognition domain or CER domain) that interacts with a Casendonuclease polypeptide. By “domain” it is meant a contiguous stretchof nucleotides that can be RNA, DNA, and/or RNA-DNA-combinationsequence. The VT domain and/or the CER domain of a single guidepolynucleotide can comprise a RNA sequence, a DNA sequence, or aRNA-DNA-combination sequence. In some embodiments the single guidepolynucleotide comprises a crNucleotide (comprising a VT domain linkedto a CER domain) linked to a tracrNucleotide (comprising a CER domain),wherein the linkage is a nucleotide sequence comprising a RNA sequence,a DNA sequence, or a RNA-DNA combination sequence. The single guidepolynucleotide being comprised of sequences from the crNucleotide andtracrNucleotide may be referred to as “single guide RNA” (when composedof a contiguous stretch of RNA nucleotides) or “single guide DNA” (whencomposed of a contiguous stretch of DNA nucleotides) or “single guideRNA-DNA” (when composed of a combination of RNA and

DNA nucleotides). In one embodiment of the disclosure, the single guideRNA comprises a cRNA or cRNA fragment and a tracrRNA or tracrRNAfragment of the type II/Cas system that can form a complex with a typeII Cas endonuclease, wherein said guide RNA/Cas endonuclease complex candirect the Cas endonuclease to a plant genomic target site, enabling theCas endonuclease to introduce a double strand break into the genomictarget site. One aspect of using a single guide polynucleotide versus aduplex guide polynucleotide is that only one expression cassette needsto be made to express the single guide polynucleotide.

The term “variable targeting domain” or “VT domain” is usedinterchangeably herein and includes a nucleotide sequence that iscomplementary to one strand (nucleotide sequence) of a double strand DNAtarget site. The % complementation between the first nucleotide sequencedomain (VT domain) and the target sequence can be at least 50%, 51%,52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 63%, 65%,66%, 67%, 68%, 69%, 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%,80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%,94%, 95%, 96%, 97%, 98%, 99% or 100%. The variable target domain can beat least 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27,28, 29 or 30 nucleotides in length. In some embodiments, the variabletargeting domain comprises a contiguous stretch of 12 to 30 nucleotides.The variable targeting domain can be composed of a DNA sequence, a RNAsequence, a modified DNA sequence, a modified RNA sequence, or anycombination thereof.

The term “Cas endonuclease recognition domain” or “CER domain” of aguide polynucleotide is used interchangeably herein and includes anucleotide sequence (such as a second nucleotide sequence domain of aguide polynucleotide), that interacts with a Cas endonucleasepolypeptide. The CER domain can be composed of a DNA sequence, a RNAsequence, a modified DNA sequence, a modified RNA sequence (see forexample modifications described herein), or any combination thereof.

The nucleotide sequence linking the crNucleotide and the tracrNucleotideof a single guide polynucleotide can comprise a RNA sequence, a DNAsequence, or a RNA-DNA combination sequence. In one embodiment, thenucleotide sequence linking the crNucleotide and the tracrNucleotide ofa single guide polynucleotide can be at least 3, 4, 5, 6, 7, 8, 9, 10,11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28,29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46,47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64,65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 78, 79, 80, 81,82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99or 100 nucleotides in length. In another embodiment, the nucleotidesequence linking the crNucleotide and the tracrNucleotide of a singleguide polynucleotide can comprise a tetraloop sequence, such as, but notlimiting to a GAAA tetraloop sequence.

Nucleotide sequence modification of the guide polynucleotide, VT domainand/or CER domain can be selected from, but not limited to, the groupconsisting of a 5′ cap, a 3′ polyadenylated tail, a riboswitch sequence,a stability control sequence, a sequence that forms a dsRNA duplex, amodification or sequence that targets the guide poly nucleotide to asubcellular location, a modification or sequence that provides fortracking, a modification or sequence that provides a binding site forproteins, a Locked Nucleic Acid (LNA), a 5-methyl dC nucleotide, a2,6-Diaminopurine nucleotide, a 2′-Fluoro A nucleotide, a 2′-Fluoro Unucleotide; a 2′-O-Methyl RNA nucleotide, a phosphorothioate bond,linkage to a cholesterol molecule, linkage to a polyethylene glycolmolecule, linkage to a spacer 18 molecule, a 5′ to 3′ covalent linkage,or any combination thereof. These modifications can result in at leastone additional beneficial feature, wherein the additional beneficialfeature is selected from the group of a modified or regulated stability,a subcellular targeting, tracking, a fluorescent label, a binding sitefor a protein or protein complex, modified binding affinity tocomplementary target sequence, modified resistance to cellulardegradation, and increased cellular permeability.

In certain embodiments the nucleotide sequence to be modified can be aregulatory sequence such as a promoter, wherein the editing of thepromoter comprises replacing the promoter (also referred to as a“promoter swap” or “promoter replacement”) or promoter fragment with adifferent promoter (also referred to as replacement promoter) orpromoter fragment (also referred to as replacement promoter fragment),wherein the promoter replacement results in any one of the following orany combination of the following: an increased promoter activity, anincreased promoter tissue specificity, a decreased promoter activity, adecreased promoter tissue specificity, a new promoter activity, aninducible promoter activity, an extended window of gene expression, amodification of the timing or developmental progress of gene expressionin the same cell layer or other cell layer (such as but not limiting toextending the timing of gene expression in the tapetum of maize anthers;see e.g. U.S. Pat. No. 5,837,850 issued Nov. 17, 1998), a mutation ofDNA binding elements and/or deletion or addition of DNA bindingelements. The promoter (or promoter fragment) to be modified can be apromoter (or promoter fragment) that is endogenous, artificial,pre-existing, or transgenic to the cell that is being edited. Thereplacement promoter (or replacement promoter fragment) can be apromoter (or promoter fragment) that is endogenous, artificial,pre-existing, or transgenic to the cell that is being edited.

Promoter elements to be inserted can be, but are not limited to,promoter core elements (such as, but not limited to, a CAAT box, a CCAATbox, a Pribnow box, a and/or TATA box, translational regulationsequences and/or a repressor system for inducible expression (such asTET operator repressor/operator/inducer elements, or SulphonylUrea (Su)repressor/operator/inducer elements. The dehydration-responsive element(DRE) was first identified as a cis-acting promoter element in thepromoter of the drought-responsive gene rd29A, which contains a 9 bpconserved core sequence, TACCGACAT (Yamaguchi-Shinozaki, K., andShinozaki, K. (1994) Plant Cell 6, 251-264). Insertion of DRE into anendogenous promoter may confer a drought inducible expression of thedownstream gene. Another example is ABA-responsive elements (ABREs)which contain a (C/T)ACGTGGC consensus sequence found to be present innumerous ABA and/or stress-regulated genes (Busk P. K., Pages M. (1998)Plant Mol. Biol. 37:425-435). Insertion of 35S enhancer or MMV enhancerinto an endogenous promoter region will increase gene expression (U.S.Pat. No. 5,196,525). The promoter (or promoter element) to be insertedcan be a promoter (or promoter element) that is endogenous, artificial,pre-existing, or transgenic to the cell that is being edited.

Single-Gene Conversion

When the term “triticale plant” is used in the context of the presentinvention, this also includes any single gene conversions of thatvariety. The term “single gene converted plant” as used herein refers tothose triticale plants which are developed by a plant breeding techniquecalled backcrossing wherein essentially all of the desired morphologicaland physiological characteristics of a variety are recovered in additionto the single gene transferred into the variety via the backcrossingtechnique. Backcrossing methods can be used with the present inventionto improve or introduce a characteristic into the variety. The term“backcrossing” as used herein refers to the repeated crossing of ahybrid progeny back to the recurrent parent, i.e., backcrossing 1, 2, 3,4, 5, 6, 7, 8, 9 or more times to the recurrent parent. The parentaltriticale plant which contributes the gene for the desiredcharacteristic is termed the “nonrecurrent” or “donor parent”. Thisterminology refers to the fact that the nonrecurrent parent is used onetime in the backcross protocol and therefore does not recur. Theparental triticale plant to which the gene or genes from thenonrecurrent parent are transferred is known as the recurrent parent asit is used for several rounds in the backcrossing protocol (Poehlman &Sleper, 1994; Fehr, 1987). In a typical backcross protocol, the originalvariety of interest (recurrent parent) is crossed to a second variety(nonrecurrent parent) that carries the single gene of interest to betransferred. The resulting progeny from this cross are then crossedagain to the recurrent parent and the process is repeated until atriticale plant is obtained wherein essentially all of the desiredmorphological and physiological characteristics of the recurrent parentare recovered in the converted plant, in addition to the singletransferred gene from the nonrecurrent parent, as determined at the 5%significance level when grown in the same environmental conditions.

The selection of a suitable recurrent parent is made for a successfulbackcrossing procedure. The goal of a backcross protocol is to alter orsubstitute a single trait or characteristic in the original variety. Toaccomplish this, a single gene of the recurrent variety is modified orsubstituted with the desired gene from the nonrecurrent parent, whileretaining essentially all of the rest of the desired genetic, andtherefore the desired physiological and morphological, constitution ofthe original variety. The choice of the particular nonrecurrent parentwill depend on the purpose of the backcross. One of the major purposesis to add some commercially desirable, agronomically important trait tothe plant. The exact backcrossing protocol will depend on thecharacteristic or trait being altered to determine an appropriatetesting protocol. Although backcrossing methods are simplified when thecharacteristic being transferred is a dominant allele, a recessiveallele may also be transferred. In this instance it may be necessary tointroduce a test of the progeny to determine if the desiredcharacteristic has been successfully transferred.

Many single gene traits have been identified that are not regularlyselected for in the development of a new variety but that can beimproved by backcrossing techniques. Single gene traits may or may notbe transgenic, examples of these traits include but are not limited to,male sterility, waxy starch, herbicide resistance, resistance forbacterial, fungal, or viral disease, insect resistance, male fertility,enhanced nutritional quality, industrial usage, yield stability andyield enhancement. These genes are generally inherited through thenucleus. Several of these single gene traits are described in U.S. Pat.Nos. 5,959,185, 5,973,234 and 5,977,445, the disclosures of which arespecifically hereby incorporated by reference.

Further reproduction of the variety can occur by tissue culture andregeneration. Tissue culture of various tissues of triticale andregeneration of plants therefrom is well known and widely published. Forexample, reference may be had to Komatsuda, T. et al., Crop Sci.31:333-337 (1991); Stephens, P. A., et al., Theor. Appl. Genet82:633-635 (1991); Komatsuda, T. et al., Plant Cell, Tissue and OrganCulture, 28:103-113 (1992); Dhir, S. et al. Plant Cell Reports11:285-289 (1992); Pandey, P. et al., Japan J. Breed. 42:1-5 (1992); andShetty, K., et al., Plant Science 81:245-251 (1992); as well as U.S.Pat. No. 5,024,944 issued Jun. 18, 1991 to Collins et al., and U.S. Pat.No. 5,008,200 issued Apr. 16, 1991 to Ranch et al. Thus, another aspectof this invention is to provide cells which upon growth anddifferentiation produce triticale plants having the physiological andmorphological characteristics of triticale cultivar 343CMS.

As used herein, the term “tissue culture” indicates a compositioncomprising isolated cells of the same or a different type or acollection of such cells organized into parts of a plant. Exemplarytypes of tissue cultures are protoplasts, calli, plant clumps, and plantcells that can generate tissue culture that are intact in plants orparts of plants, such as embryos, pollen, ovules, pericarp, flowers,florets, heads, spikes, seeds, leaves, stems, roots, root tips, anthers,awns, stems, and the like. Means for preparing and maintaining planttissue culture are well known in the art. By way of example, a tissueculture comprising organs has been used to produce regenerated plants.U.S. Pat. Nos. 5,959,185, 5,973,234 and 5,977,445, describe certaintechniques.

Also provided are methods for producing a triticale plant by crossing afirst parent triticale plant with a second parent triticale plantwherein the first or second parent triticale plant is a triticale plantof the cultivar 343CMS. Thus, any such methods using the triticalecultivar 343CMS are part of this invention: backcrosses, hybridproduction, crosses to populations, and the like. All plants producedusing triticale cultivar 343CMS as a parent are within the scope of thisinvention, including those developed from varieties derived fromtriticale cultivar 343CMS. Advantageously, the triticale cultivar couldbe used in crosses with other, different, triticale plants to producefirst generation (F₁) triticale hybrid seeds and plants with superiorcharacteristics. The cultivar of the invention can also be used fortransformation where exogenous genes are introduced and expressed by thecultivar of the invention. Genetic variants created either throughtraditional breeding methods using cultivar 343CMS or throughtransformation of 343CMS by any of a number of protocols known to thoseof skill in the art are intended to be within the scope of thisinvention.

The following describes breeding methods that may be used with cultivar343CMS in the development of further triticale plants. One suchembodiment is a method for developing an 343CMS progeny triticale plantin a triticale plant breeding program comprising: obtaining thetriticale plant, or a part thereof, of cultivar 343CMS utilizing saidplant or plant part as a source of breeding material and selecting an343CMS progeny plant with molecular markers in common with 343CMS and/orwith morphological and/or physiological characteristics selected fromthose described above. Breeding steps that may be used in the triticaleplant breeding program include pedigree breeding, back crossing,mutation breeding, and recurrent selection. In conjunction with thesesteps, techniques such as RFLP-enhanced selection, genetic markerenhanced selection (for example SSR markers) and the making of doublehaploids may be utilized.

Another method involves producing a population of cultivar 343CMSprogeny triticale plants, comprising crossing cultivar 343CMS withanother triticale plant, thereby producing a population of triticaleplants, which, on average, derive 50% of their alleles from cultivar343CMS. A plant of this population may be selected and repeatedly selfedor sibbed with a triticale cultivar resulting from these successivefilial generations. One embodiment of this invention is the triticalecultivar produced by this method and that has obtained at least 50% ofits alleles from cultivar 343CMS.

One of ordinary skill in the art of plant breeding would know how toevaluate the traits of two plant varieties to determine if there is nosignificant difference between the two traits expressed by thosevarieties. For example, see Fehr and Walt, Principles of CultivarDevelopment, p 261-286 (1987). Thus the invention includes triticalecultivar 343CMS progeny triticale plants comprising a combination of atleast two 343CMS traits selected from the group consisting of thoselisted here so that said progeny triticale plant is not significantlydifferent for said traits than triticale cultivar 343CMS as determinedat the 5% significance level when grown in the same environment. Usingtechniques described herein, molecular markers may be used to identifysaid progeny plant as a 343CMS progeny plant. Mean trait values may beused to determine whether trait differences are significant, andpreferably the traits are measured on plants grown under the sameenvironmental conditions. Once such a variety is developed its value issubstantial since it is important to advance the germplasm base as awhole in order to maintain or improve traits such as yield, diseaseresistance, pest resistance, and plant performance in extremeenvironmental conditions.

Progeny of cultivar 343CMS may also be characterized through theirfilial relationship with triticale cultivar 343CMS, as for example,being within a certain number of breeding crosses of triticale cultivar343CMS. A breeding cross is a cross made to introduce new genetics intothe progeny, and is distinguished from a cross, such as a self or a sibcross, made to select among existing genetic alleles. The lower thenumber of breeding crosses in the pedigree, the closer the relationshipbetween triticale cultivar 343CMS and its progeny. For example, progenyproduced by the methods described herein may be within 1, 2, 3, 4 or 5breeding crosses of triticale cultivar 343CMS.

Further, testing was completed showing changes in the genes Atp8-1, NAD9and NAD4L that differentiate the cytoplasm as outlined below. Thefollowing is presented by way of exemplification and is not intended tolimit the scope of the invention.

Example 1

Methodology: Mitochondrial genome and mitochondrial specific genes(Coxa, Atp8-1, NAD9, and NAD4L) of the triticale line of the disclosureand other 15 lines with known cytoplasm were used in the study (detailsregarding the lines is provided in Table 1). Multiple sequence alignmentof nucleotide sequences was performed using sequence alignment tool ofCLC sequence viewer software with default settings (gap open cost=10 andgap extension cost=1).

Results: Cytoplasmic diversity of Triticale line 343CMS with unknowncytoplasm from cytoplasm of known cytoplasmic male sterile lines/sources(Table 2) was studied by mitochondrial genome of all those lines thatcarry mitochondrial specific genes. Multiple sequence alignment of fourknown mitochondrial genes (Cox3, Atp8-1, NAD9, NAD4L) from themitochondrial genome revealed that there is specific sequence change atnucleotide level that differentiates cytoplasm of two lines from thecytoplasm of known sources of male sterility. See FIGS. 1-4 where eachof the compared sequences in the figures are numbered 1-11 and 13-17 andcorrespond to Table 2. Based on sequence comparison of Cox3 gene,cytoplasm of line 343CMS didn't carry any distinct sequence change thatdifferentiated it's Cox3 gene from other accessions under study (FIG. 1). Similar comparison for gene Atp8-1, revealed that line 3-4-3 carriedsequence change at positions 155, 176, 186, 286, 295, and 337 bp thatdifferentiated its cytoplasm from other accessions under study. (FIG. 2). Sequence comparison of gene NAD9 revealed that cytoplasmic gene NAD9of lines 3-4-3 is distinct from all the known sources of cytoplasmsterility due to sequence change at position 170 and 338 bp. Furthersequence comparison based on gene NAD4L for all the accessions understudy revealed that line 343CMS was carried sequence change at position51, 54, 57, 89, 99, 106, 159, 181, 185, 199, 220, 226, and 425 to 429bp.

Conclusion: Sequence comparison at nucleotide level between known malecytoplasmic sterile lines and Triticale line 343CMS suggests thatcytoplasm of the line is distinct from known male sterile lines. Theline can be differentiated from cytoplasm of other known sources of malesterility using sequence diversity present in the gene NAD9, that isunique to only these two lines. Further, uniqueness of the line'scytoplasm from all the accessions under study is revealed by presence ofsequence change specific to this accession in gene Atp8-1 and NAD4L.

Marker development: KASP markers can be developed around these sequencechanges for detection of cytoplasm of line 343CMS.

The sequences of FIG. 1 are, respectively SEQ ID NOS 1-16; in FIG. 2 arerespectively SEQ ID NOS 17-32 and FIG. 3 are respectively 33-48; and inFIG. 4 are respectively 49-64. Based on sequence comparison of Cox3gene, cytoplasm of line 343CMS didn't carry any distinct sequence changethat differentiated it's Cox3 gene from other accessions under study(FIG. 1 ). Similar comparison for gene Atp8-1, revealed that line 3-4-3carried sequence change at positions 155, 176, 186, 286, 295, and 337 bp(see SEQ ID NO: 32) that differentiated its cytoplasm from otheraccessions under study. (FIG. 2 ). Sequence comparison of gene NAD9revealed that cytoplasmic gene NAD9 of lines 3-4-3 is distinct from allthe known sources of cytoplasm sterility due to sequence change atposition 170 and 338 bp. (SEQ ID NO 48 NAD 9-12 FIG. 3 ). Furthersequence comparison based on gene NAD4L for all the accessions understudy revealed that line 343CMS was carried sequence change at position51, 54, 57, 89, 99, 106, 159, 181, 185, 199, 220, 226, and 425 to 429bp. SEQ ID NO: 64).

TABLE 2 Accessions used to study the cytoplasmic diversity of Triticaleline 343CMS Material Accession Remarks 1 Aegilops sharonensis TA#1996 2Ae. sharonensis TA#1998 3 Ae. sharonensis TA#2174 4 Ae. sharonensisTA#10414 5 Ae. sharonensis cytoplasm TA#6003 alloplasmic lines, Selkirknucleus 6 Ae. sharonensis cytoplasm TA#6005 alloplasmic lines, Selkirknucleus 7 Ae. sharonensis cytoplasm TA#6006 alloplasmic lines, Selkirknucleus 8 Triticum zhukovskyi TA#2610 9 T. zhukovskyi TA#10866 10 WheatA line A 385-5 T. timopheevii cytoplasm 11 Wheat B line B 385-5 T.aestivum cytoplasm 12 Triticale A line 3-4-3 Unknown cytoplasm 13Triticale B line 3-4-4 Durum wheat cytoplasm 16 718S Ae. sharonensis 17SY718 Durum wheat cytoplasm

A CLUSTAL, multiple sequence alignment by MUSCLE (3.8) of a wild typereference NAD9 nucleotide sequence (SEQ ID NO: 67; see GenBankAP008982.1) and the 434CMS NAD9 nucleotide sequence (SEQ:11) NO: 68) isshown below:

67 ATGCTCTGTATAATACTTTTCCCCGAGCGATGGTTTAGCGGATTCGGAATTGTAACCAAG 68ATGCTCTGTATAATACTTTTCCCCGAGCGATGGTTTAGCGGATTCGGAATTGTAACCAAG************************************************************ 67CATCCTGGGTTCTATACCCGATTCAACACTAGAGCATGCAGCCGATCCTGGATACATAAC 68CATCCTGGGTTCTATACCCGATTCAACACTAGAGCATGCAGCCGATCCTGGATACATCAC********************************************************* ** 67TCTAAAAAGTGTGTGTGCAGTTTTGGATCTTTATTGGTAGCCAGTCTTTCACTTCTGCCT 68TATATAAAGTGTGCATGCAGTTTTGGATCTTTATTGGTAGCCAGTCTTTCACTTCTGCCT* ** ******** ********************************************* 67CTCCACTCCCATGCCTTTCTTGGTCGGACCAACCCAACCGGCGATTTCCGACAAGTCTTT 68CTCCACTCCCATGCCTTTCTTGGTCGGACCAACCCAACCGGCGATTTCCGACAAGTCTTT************************************************************ 67CTGCTTAGAGCAAGAAGCGGAACCAAAATAAAGCTTTCTTTATTTTCATTTATGGATAAC 68CTGCTTAGAGCAAGAAGCGGAACCAAAATAAAGCTTTCTTTATTTGCATTTATGGATAAC********************************************* ************** 67CAATCCATTTTCCAATATAGTTGGGAGATTTTACCCAAGAAATGGGTACATAAAATGAAA 68CAATCCATTTTCCAATATAGTTGGGAGATTTTACCCAAGAAATGGGTACATAAAATGAAA************************************************************ 67AGATCGGAACATGGGAATAGATCTTATACCAATACTGACTACCCATTTCCATTGTTGTGC 68AGATCGGAACATGGGAATAGATCTTATACCAATACTGACTACCCATTTCCATTGTTGTGC************************************************************ 67TTTCTAAAATGGCATACCTATACAAGGGTTCAAGTTTCGATCGATATTTGCGGAGTGGAT 68TTTCTAAAATGGCATACCTATACAAGGGTTCAAGTTTCGATCGATATTTGCGGAGTGGAT************************************************************ 67CATCCCTCTCGAAAACGAAGATTTGAAGTTGTCCATAATTTACTGAGTACTCGGTATAAC 68CATCCCTCTCGAAAACGAAGATTTGAAGTTGTCCATAATTTACTGAGTACTCGGTATAAC************************************************************ 67TCACGCATTCGTGTACAAACAAGTGCAGACGAAGTAACACGAATATCTCCGGTAGTCAGT 68TCACGCATTCGTGTACAAACAAGTGCAGACGAAGTAACACGAATATCTCCGGTAGTCAGT************************************************************ 67CTATTTCCATCAGCCGGCCGGTGGGAGCGAGAAGTATGGGATATGTCTGGTGTTTCTTCC 68CTATTTCCATCAGCCGGCCGGTGGGAGCGAGAAGTATGGGATATGTCTGGTGTTTCTTCC************************************************************ 67ATCAATCATCCGGATTTACGCCGTATATCAACAGATTATGGTTTCGAGGGTCATCCATTA 68ATCAATCATCCGGATTTACGCCGTATATCAACAGATTATGGTTTCGAGGGTCATCCATTA************************************************************ 67CGAAAAGACTTTCCTCTGAGTGGATATGTGGAAGTACGCTATGATGATCCAGAGAAACGT 68CGAAAAGACTTTCCTCTGAGTGGATATGTGGAAGTACGCTATGATGATCCAGAGAAACGT************************************************************ 67GTGGTTTCTGAACCCATTGAGATGACCCAAGAATTTCGCTATTTCGATTTTGCTAGTCCT 68GTGGTTTCTGAACCCATTGAGATGACCCAAGAATTTCGCTATTTCGATTTTGCTAGTCCT************************************************************ 67TGGGAACAGCGTAGCGACGGATAA 68 TGGGAACAGCGTAGCGACGGATAA************************

A CLUSTAL multiple sequence alignment by MUSCLE (3.8) of a wild typereference NAD9 protein (SEQ ID NO: 71; see GenBank AP008982.1) and the434CMS NAD9 protein sequence (SEQ ID NO: 72) is shown below:

71 MLCIILFPERWFSGFGIVTKHPGFYTRFNTRACSRSWIHNSKKCVCSFGSLLVASLSLLP 72MLCIILFPERWFSGFGIVTKHPGFYTRFNTRACSRSWIHHYIKCACSFGSLLVASLSLLP***************************************:  **.*************** 71LHSHAFLGRTNPTGDFRQVFLLRARSGTKIKLSLFSFMDNQSIFQYSWEILPKKWVHKMK 72LHSHAFLGRTNPTGDFRQVFLLRARSGTKIKLSLFAFMDNQSIFQYSWEILPKKWVHKMK***********************************:************************ 71RSEHGNRSYTNTDYPFPLLCFLKWHTYTRVQVSIDICGVDHPSRKRRFEVVHNLLSTRYN 72RSEHGNRSYTNTDYPFPLLCFLKWHTYTRVQVSIDICGVDHPSRKRRFEVVHNLLSTRYN************************************************************ 71SRIRVQTSADEVTRISPVVSLFPSAGRWEREVWDMSGVSSINHPDLRRISTDYGFEGHPL 72SRIRVQTSADEVTRISPVVSLFPSAGRWEREVWDMSGVSSINHPDLRRISTDYGFEGHPL************************************************************ 71RKDFPLSGYVEVRYDDPEKRVVSEPIEMTQEFRYFDFASPWEQRSDG 72RKDFPLSGYVEVRYDDPEKRVVSEPIEMTQEFRYFDFASPWEQRSDG***********************************************

DEPOSIT

Applicant(s) have made a deposit of at least 625 seeds of triticalevariety 343CMS with the American Type Culture Collection (ATCC),Manassas, Va. 20110 USA, ATCC Deposit No. PTA-126905. The seedsdeposited with the ATCC on Nov. 24, 2020 were taken from the depositmaintained by Northern Agri Brands, LLC, 205 9^(th) Ave. S., Suite 205,Great Falls, Mont. 59405, since prior to the filing date of thisapplication. Access to this deposit will be available during thependency of the application to the Commissioner of Patents andTrademarks and persons determined thereby to be entitled thereto uponrequest. Upon issue of claims, the Applicant(s) will make available tothe public, pursuant to 37 CFR 1.808(2), a deposit of at least 625 seedsof variety 343CMS with the American type Culture Collection (ATCC),10801 University Boulevard, Manassas, Va. 20110-2209. Additionally,Applicant(s) have satisfied all the requirements of 37 C.F.R. §1.801-1.809, including providing an indication of the viability of thesample. These deposits will be maintained in the ATCC Depository, whichis a public depository, for a period of 30 years, or 5 years after themost recent request, or for the enforceable life of the patent,whichever is longer, and will be replaced if it ever becomes nonviableduring that period. Applicant has no authority to waive any restrictionsimposed by law on the transfer of biological material or itstransportation in commerce. Applicant does not waive any infringement ofits rights granted under this patent or under the Plant VarietyProtection Act (7 USC 2321 et seq.).

What is claimed is:
 1. A seed of triticale cultivar 343CMS, wherein arepresentative sample of seed of said cultivar has been deposited underATCC Accession No. PTA-126905.
 2. A triticale plant, or a part thereof,produced by growing the seed of claim
 1. 3. A tissue culture of cellsproduced from the plant of claim 2, wherein said cells of the tissueculture are produced from a plant part selected from the groupconsisting of heads, awns, leaves, pollen, embryos, cotyledons,hypocotyls, meristematic cells, roots, root tips, pistils, anthers,flowers, stems, and calli.
 4. A protoplast produced from the plant ofclaim
 2. 5. A protoplast produced from the tissue culture of claim
 3. 6.A triticale plant regenerated from the tissue culture of claim 3,wherein the plant has all of the morphological and physiologicalcharacteristics of cultivar 343CMS wherein a representative sample ofseed was deposited under ATCC Accession No. PTA-126905.
 7. A method forproducing an F₁ triticale seed, wherein the method comprises crossingthe plant of claim 2 with a different triticale plant or a plant of343CMS having restored male fertility and harvesting the resultant F₁hybrid triticale seed.
 8. A The F₁ hybrid triticale seed produced by themethod of claim
 7. 9. A triticale plant, or a part thereof, produced bygrowing said seed of claim
 8. 10. An F₁ hybrid triticale plant or partthereof produced by crossing the triticale plant of claim 2, with adifferent triticale plant.
 11. A method of introducing a desired traitinto triticale cultivar 343CMS wherein the method comprises: (a)crossing a 343CMS plant, wherein a representative sample of seed wasdeposited under ATCC Accession No. PTA-126905, with a plant of anothertriticale cultivar that comprises a desired trait to produce progenyplants wherein the desired trait is selected from the group consistingof male sterility, herbicide resistance, insect resistance, modifiedfatty acid metabolism, modified carbohydrate metabolism, modified phyticmetabolism, modified waxy starch content, modified gluten content andresistance to bacterial disease, fungal disease or viral disease; (b)selecting one or more progeny plants that have the desired trait toproduce selected progeny plants; (c) crossing the selected progenyplants with the 343CMS plants to produce backcross progeny plants; (d)selecting for backcross progeny plants that have the desired trait andare otherwise phenotypically indistinguishable from triticale cultivar343CMS listed in Table 1 to produce selected backcross progeny plants;and (e) repeating steps (c) and (d) three or more times in succession toproduce selected fourth or higher backcross progeny plants that comprisethe desired trait and are otherwise phenotypically indistinguishablefrom triticale cultivar 343CMS.
 12. A triticale plant or plant partproduced by the method of claim 11, wherein the plant has the desiredtrait and is otherwise phenotypically indistinguishable from triticalecultivar 343CMS.
 13. A method of introducing male sterility into adesired triticale or wheat plant wherein the method comprises: (a)crossing a 343CMS plant, wherein a representative sample of seed wasdeposited under ATCC Accession No. PTA-126905, with the triticale orwheat plant to produce at least one progeny plant.
 14. An F₁ malesterile plant produced by the method of claim
 13. 15. The F₁ malesterile plant of claim 14, wherein the plant comprises thepolynucleotide of SEQ ID NO: 64, 66, or
 68. 16. The F₁ male sterileplant of claim 14, wherein the plant is a triticale plant.
 17. The F₁male sterile plant of claim 14, wherein the plant is a wheat plant. 18.The method of claim 13, further comprising the steps of: (b) selectingone or more progeny plants that have the male sterility trait to produceselected progeny plants; and (c) using the selected progeny plants as asource of breeding material to develop further progeny plants.
 19. Themethod of claim 13, further comprising: assaying one or more progenyplants for the presence of the polynucleotide of SEQ ID NO: 64, 66, or68.
 20. A triticale or wheat plant comprising a mitochondrialpolynucleotide associated with cytoplasmic male sterility as present intriticale cultivar 343CMS, wherein a representative sample of seed ofthe cultivar has been deposited under ATCC Accession No. PTA-126905, andwherein the plant is an F₁ progeny of triticale cultivar 343CMS.
 21. Thetriticale or wheat plant of claim 20, wherein the plant comprises thepolynucleotide of SEQ ID NO: 64, 66, or 68.